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Abstract
In 2012, a controversial study on the long-term toxicity of a Roundup herbicide and the glyphosate-tolerant genetically modi-
fied (GM) maize NK603 was published. The EC-funded G-TwYST research consortium tested the potential subchronic and 
chronic toxicity as well as the carcinogenicity of the glyphosate-resistant genetically modified maize NK603 by performing 
two 90-day feeding trials, one with GM maize inclusion rates of 11 and 33% and one with inclusion rates of up to 50%, as 
well as a 2-year feeding trial with inclusion rates of 11 and 33% in male and female Wistar Han RCC rats by taking into 
account OECD Guidelines for the testing of chemicals and EFSA recommendations on the safety testing of whole-food/feed 
in laboratory animals. In all three trials, the NK603 maize, untreated and treated once with Roundup during its cultivation, 
and the conventional counterpart were tested. Differences between each test group and the control group were evaluated. 
Equivalence was assessed by comparing the observed difference to differences between non-GM reference groups in pre-
vious studies. In case of significant differences, whether the effects were dose-related and/or accompanied by changes in 
related parameters including histopathological findings was evaluated. It is concluded that no adverse effects related to the 
feeding of the NK603 maize cultivated with or without Roundup for up to 2 years were observed. Based on the outcome of 
the subchronic and combined chronic toxicity/carcinogenicity studies, recommendations on the scientific justification and 
added value of long-term feeding trials in the GM plant risk assessment process are presented.
Keywords Genetically modified maize NK603 · GMO risk assessment · Biosafety · G-TwYST · OECD Test Guideline 
No. 408 · OECD Test Guideline No. 453 · Rat feeding trial · Subchronic oral toxicity study · Combined chronic toxicity/
carcinogenicity study
Introduction
Since the mid-1990s, genetically modified (GM) crops have 
increasingly been grown commercially around the world, 
reaching a global acreage of 189.8 million hectares planted 
by farmers worldwide, particularly in non-EU countries, 
such as USA, Brazil, Argentina, Canada, and India. The 
four major cultivated commodity crops are soybean, maize, 
oilseed rape, and cotton, whilst a wide range of other GM 
crops, fruits, and vegetables are grown to a lesser extent. 
The main traits that have been introduced through genetic 
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modification are herbicide tolerance and insect resistance 
(ISAAA 2017).
In many countries around the world, GM crops are only 
allowed onto the market after a regulatory approval or con-
sultation procedure, which entails, amongst others, a pre-
market safety assessment. To assess the safety of foods 
derived from GM crops, the FAO/WHO Codex Alimen-
tarius established internationally harmonized guidelines 
(Codex Alimentarius 2008). Central to the safety assess-
ment is the comparison of a given GM crop with a geneti-
cally near non-GM counterpart with a history of safe use, 
focusing on the differences between both, identifying both 
intended and unintended effects of the genetic modification. 
This entails, amongst others, a comprehensive analysis of 
the compositional characteristics of these comparators, 
including nutrients (e.g. amino acids, fatty acids, vitamins 
and minerals), anti-nutrients, toxins, and other compounds 
of biological relevance (e.g. phytoestrogens). Based on the 
differences thus identified and the information already avail-
able on the possible safety implications of such changes, 
it can be determined if and how the further safety assess-
ment should be performed before reaching a conclusion. For 
newly expressed proteins encoded by the introduced foreign 
genes, the assessment may, for example, address their poten-
tial toxicity and allergenicity through the performance of a 
number of in silico, in vitro or in vivo tests (Codex Alimen-
tarius 2008).
Besides the above-mentioned compositional analysis, 
testing of whole food products may be considered in some 
exceptional cases, whilst it has to be realized that foods are 
complex mixtures and, unlike purified chemicals, there are 
boundaries to the dose ranges that can be tested in experi-
mental animals, thereby diminishing the sensitivity of such 
tests (Codex Alimentarius 2008). In the EU, the require-
ments for the risk assessment of GM food/feed are specified 
in detail by the Implementing Regulation No. 503/2013 (EU 
2013a), which takes into account the Codex Alimentarius 
guideline for the conduct of food safety assessment of foods 
derived from GM plants (Codex Alimentarius 2008).
According to the Implementing Regulation No. 503/2013, 
applicants are requested to carry out an obligatory 90-day 
feeding study with whole food/feed for each GMO event 
to be marketed in the EU, although various stakeholders 
presented scientific arguments not unanimously supporting 
this requirement (see e.g. Devos et al. 2016). Depending 
on the outcome of previous studies, a 2-year carcinogenic-
ity study with rats may also be requested by the European 
Food Safety Authority (EFSA) on a case-by-case basis. To 
prepare for such eventualities, EFSA was asked by the Euro-
pean Commission to provide supplementary guidance on key 
elements to be considered for a 2-year carcinogenicity trial 
in rats with whole food/feed. Against this backdrop and to 
address possible concerns after the publication of a study 
on the long-term toxicity of Roundup, a glyphosate-based 
herbicide formulation and the glyphosate-tolerant geneti-
cally modified maize NK603 (Séralini et al. 2012; EFSA 
2012), the European Commission funded the 4-year research 
project G-TwYST (GM Plant Two Year Safety Testing) to 
address the following issues related to 2-year feeding trials 
in a stepwise approach: (1) the execution of at least one rat 
feeding trial with the GM maize NK603 applying EFSA 
protocols and recommendations, whereby the participating 
institutions should strictly comply with all applicable inter-
national standards and norms concerning feeding trials in 
close collaboration with EFSA; (2) analysis, report and pro-
vision of recommendations, in particular as to the scientific 
justification and added value of such long-term feeding trials 
with regard to GMO risk assessment.
To achieve the first objective, the G-TwYST partners per-
formed three rat feeding studies with GM maize NK603, 
both untreated and treated once with  Roundup® during its 
cultivation, as well as the untreated conventional counterpart 
as control:
• two 90-day trials for subchronic toxicity testing, one with 
GM maize inclusion rates of 11 and 33% and one with 
GM maize inclusion rates of 11, 33 and 50% as well as
• a combined chronic toxicity/carcinogenicity (2-year) 
study with GM maize inclusion rates of 11 and 33%,
all three of them based on the OECD Guidelines for the 
testing of chemicals (OECD 1998, 2009a) and EFSA recom-
mendations (EFSA 2011a, 2013, 2014). A 90-day feeding 
trial with a maize incorporation rate of 50% was included, 
since EFSA (2014) proposed it as the reference value for 
a high maize dose in 90-day studies in rodents, based on a 
report by Zhu et al. (2013). Furthermore, various stakehold-
ers strongly supported the performance of a 90-day feed-
ing trial with a maize incorporation rate of 50% at the first 
G-TwYST Stakeholder Meeting held in Vienna, Austria, in 
December 2014.
In the present study, the results of the three above-men-
tioned feeding trials are described and discussed. Based on 
the results obtained, the conclusions and recommendations 
of the G-TwYST consortium on the design, conduct and 
analysis of rat feeding studies with whole food/feed, as well 
as the scientific justification and added value of long-term 
feeding trials for the GM plant risk assessment are presented.
Materials and methods
Plant material
Given that the NK603 maize had been approved in the EU 
for import, processing as well as food and feed uses but 
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not for cultivation, the NK603 and control maize plants 
were cultivated according to good agricultural practice in 
an experimental field station of the University of Guelph 
(ON, Canada) in 2014. Two varieties were produced: the 
GM maize NK603 (Pioneer 8906 R), without and with a 
Roundup application during cultivation, and its near-isogenic 
non-GM comparator (Pioneer 8906). About 84,000 plants/
ha were planted in May 2014, the non-GM seeds on the 
13th of May 2014 and the GM seeds on the 14th of May 
2014. Weeds were controlled by applying  Primextra® II 
 Magnum® (S-Metolachlor + Atrazine, 3.5 L/ha) on the 20th 
of May 2014 at all sites and Roundup  Transorb® HC (2.5 L/
ha, 1.35 kg glyphosate [potassium salt]/ha) at the “Roundup 
site” on the 20th of June 2014. GM maize and non-GM 
maize were grown on a farm in a distance of about 1 km 
to avoid cross pollination. Glyphosate-treated and untreated 
fields were separated by a field road. Maize was harvested 
in November 2014 and kernels were removed from the cobs 
on-site by machine. They had grain moisture levels in the 
usual range and were dried in a biological dryer, kept below 
60 °C, down to a moisture level of 13–14%.
Diet preparation and analyses
Four tons of GM maize NK603, four tons of Roundup-
treated GM maize NK603 and 7.8 tons of the near-isogenic 
non-GM comparator (maize kernels) were transported on the 
14th of December 2014 to Germany (air freight) and stored 
in big bags in a commercial storage facility not storing other 
grains and under ambient climate conditions. No other plant 
material was stored at the facility. The quality of the kernels 
was analysed after import. The sampling of the big bags 
(i.e. kernels from the same variety and treatment) was per-
formed according to Regulation 691/2013 (EU 2013b) by 
a representative of the Landesuntersuchungsanstalt für das 
Gesundheits- und Veterinärwesen Sachsen in January 2015.
In autumn 2015, an infestation with the Indian meal moth 
(Plodia interpunctella) was noticed and a fumigation with 
phosphine, which does not leave residues on/in the stored 
kernels, took place. The big bags were moved to another 
storage facility and stored under ambient climate conditions 
between November 2015 and April 2017 (storage conditions: 
12.3 ± 6.2 °C, 64.6 ± 7.2% humidity, hourly recorded). In 
summer 2016, mice were viewed in the storing hall, so that 
the kernels were sieved and placed in rigid containers.
Kernels were shipped to ENVIGO/Mucedola srl (Milan, 
Italy), milled (mesh size: 1 mm) to prepare the feed. The 
formulation of the diets was calculated by the nutritionist of 
the company based on their standard feeds and ingredients 
for all feeding trials to provide a balanced nutrition. The 
feeds were isoproteic, isocaloric and adjusted to the dietary 
requirements of the rat strain Wistar Han RCC used in the 
feeding trials. Besides the milled maize, the formulation 
mainly consisted of other plant-derived ingredients, includ-
ing wheat, wheat middlings, soybean meal, soybean oil and 
a rice protein concentrate, while it did not contain animal-
derived ingredients (Supplementary Electronic Material, 
Table 1). Except for the GM maize, the other ingredients of 
the diets were supposed to be GM-free, but traces of GMO 
(traits) were frequently detected: this information is docu-
mented in the diet analyses file that can be accessed via the 
internet portal named CADIMA (Central Access Database 
for Impact Assessment of Crop Genetic Improvement Tech-
nologies; http://www.cadim a.info). Traces of GMO (traits) 
were also detected in the commercially available seeds of 
control maize. The pellets were dried at a temperature of 
< 50 °C, coded in a blinded fashion and sent to the Slovak 
Medical University (Bratislava, Slovakia) for the feeding 
trials as vacuum-packed, γ-irradiated batches (irradiation 
dose = 25 kGy).
Diets were produced in six batches. A re-coded part of 
batch 3 of all diet groups was used for the 90-day feeding 
trial with a GM maize inclusion rate of 11 and 33% (com-
plemented with the near-isogenic variety up to 33% maize 
in toto), whereas a separate batch of diets was prepared for 
the 90-day feeding trial with a GM maize inclusion rate of 
up to 50% (complemented with the near-isogenic variety 
up to 50% maize in toto). Maize and diet subsamples were 
retained at the animal feed producing facility (Mucedola srl) 
for analysis. Irradiated diet samples of > 1.5 kg each were 
sent to the Julius Kühn-Institut (Quedlinburg, Germany) and 
stored at − 80 °C. Batches 1, 3 and 5 were analysed. Diet 
samples for analyses were shipped to RIKILT Wageningen 
University and Research, where the feed pellets were milled 
and re-mixed. Subsamples of the milled material were ana-
lysed by RIKILT and for complementary analyses either dis-
patched to Covance (Madison, WI, USA) or SGS (Hamburg, 
GER). The parameters measured and the methods applied 
by each of the certified laboratories are listed in the diet 
analyses file (http://ww.cadim a.info).
Study design
The study design of the two 90-day feeding trials (Tables 1, 
7) was based on the OECD Test Guideline 408 for the test-
ing of chemicals (OECD 1998) and EFSA recommenda-
tions on the performance of 90-day rodent feeding trials with 
whole food/feed (EFSA 2011a, 2014). The study design of 
the combined chronic toxicity/carcinogenicity feeding trial 
(Table 11) was based on the OECD Test Guideline 453 
(OECD 2009) and EFSA considerations on the applicability 
of OECD TG 453 to whole food/feed (EFSA 2013).
As recommended by EFSA (2011a), two animals of the 
same gender were housed per cage and the cage was taken 
as the experimental unit. In the 90-day feeding trial with a 
GM maize NK603 inclusion rate of 11 and 33%, as well as 
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in the combined chronic toxicity/carcinogenicity study there 
were five feeding groups (Tables 1, 11) and in the 90-day 
feeding trial with a GM maize inclusion rate of up to 50% 
there were eight feeding groups (Table 7). The cages were 
organized in blocks of 5–8 cages, and the feeding groups 
were randomized within blocks, i.e. a completely rand-
omized block design was applied in all three feeding trials. 
There were separate blocks with male and female rats. To 
keep the units within blocks as homogeneous as possible, the 
ten heaviest rats of each sex (based on the weights 48 h after 
arrival) were housed in the first block, the next ten heaviest 
rats of each sex were housed in block 2, and so on. Except 
for feed consumption, which was determined per cage, all 
other parameters were measured in individual animals.
Rat feeding trials
The trials were performed in compliance with GLP in the 
experimental animal facility at the Department of Toxicol-
ogy of the Slovak Medical University in Bratislava (Slova-
kia). Five-week-old male and female specific-pathogen-free 
Wistar Han RCC (RccHan™:WIST) rats were purchased 
from Envigo (San Pietro al Natisone, Italy). A large amount 
of histopathological data has been published on the three 
main strains of rat used in carcinogenicity studies, i.e. Wistar 
Han, Sprague–Dawley, and Fischer 344 (Weber 2017). It is 
well known that Fischer 344 rats are prone to develop spon-
taneous myeloid leukemia and Leydig cell tumours, while 
Sprague–Dawley rats show high incidence rates in the case 
of spontaneous pituitary gland adenomas and mammary 
gland neoplasms (Weber 2017). The Wistar Han rat strain 
was used to perform the three feeding trials described in this 
paper because it shows the lowest incidence of spontaneous 
tumours in most organs when compared to the Fischer 344 
and Sprague–Dawley strains.
The feeding trials were started 1 week after delivery of 
the animals at the animal testing facility. A detailed exami-
nation of all animals to verify their health condition (see the 
section “Periodical health status observations”) was carried 
out just before the start of the feeding trials. Feed and water 
were supplied ad libitum; feed was changed once a week and 
water every day. Feed consumption was determined once 
weekly during the first 13 weeks, every 2 weeks thereafter 
and reported as the total amount of feed consumed by two 
animals in one cage per week or 2 weeks, respectively.
Periodical health status observations
Rats were inspected twice daily for changes in skin, fur, 
eyes, mucous membranes, occurrence of secretions and 
excretions as well as activity level and change in behaviour. 
A detailed physical examination of each animal out of the 
cage was performed prior to the beginning of the feeding 
trials, on day 1, once weekly during the first 13 weeks and 
once monthly thereafter to identify changes in skin, fur, eyes, 
mucous membranes, occurrence of secretions and excre-
tions, autonomic activity such as lacrimation, piloerection, 
pupil size, unusual respiratory patterns as well as activity 
level and change in behaviour. At the end of the feeding 
trials a functional assessment of changes in gait, posture 
and response to handling, as well as the presence of clonic 
or tonic movements or bizarre behaviour (self-mutilation, 
walking backwards) was carried out. Sensory reactivity to 
auditory, visual and proprioceptive stimuli was recorded. An 
ophthalmologic examination of both eyes of all animals in 
the conscious state was performed prior to the beginning of 
the feeding trials and 2 weeks before the end of the studies. 
The eyes and the peribulbar structures were examined mac-
roscopically after pupillary dilatation induced by instillation 
of a 0.5% tropicamide solution. Each animal was weighed 
48 h after its arrival at the experimental animal facility of the 
Slovak Medical University, on the randomization day (i.e. 
day − 1), on the first day of the feeding trials, once weekly 
during the first 13 weeks, once every 2 weeks thereafter and 
at the end of the studies.
Haematology and clinical biochemistry analyses
In the case of the two 90-day feeding trials, blood samples 
from the tail vein of 16 males and 16 females per group 
after 16–18 h fasting were taken at the end of the study for 
the haematological analyses (with EDTA as anticoagulant) 
as well as for the clinical biochemistry analyses (without 
anticoagulant). In the case of the combined chronic toxicity/
carcinogenicity study, at the end of months 3 and 6, blood 
samples from the tail vein of 40 males and 40 females per 
group after 16–18 h fasting were taken for the haematologi-
cal and clinical biochemistry analyses in the same way as 
described above. At months 12 and 24, blood samples were 
taken from all animals in the different groups.
No later than 4 h after collection of the blood samples 
the following haematology parameters were measured by 
making use of a Sysmex K-4500 automated haematology 
analyser (Sysmex, Kobe, Japan): white blood cell count 
(WBC), red blood cell count (RBC), haemoglobin con-
centration (HGB), haematocrit (HCT), mean cell volume 
(MCV), mean corpuscular haemoglobin (MCH), mean 
corpuscular haemoglobin concentration (MCHC), platelet 
count (PLT) as well as the absolute (LYMA) and relative 
lymphocyte count (LYMR). For the differential leukocyte 
count, blood smears were stained with the May–Grunwald 
and Giemsa–Romanowski dyes and thereafter examined by 
light microscopy; the percentage lymphocytes, neutrophils, 
eosinophils, basophils and monocytes were determined by 
examining 200 cells.
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The parameters alkaline phosphatase (ALP), alanine 
aminotransferase (ALT), aspartate aminotransferase (AST), 
albumin (ALB), total protein (TP), glucose (GLU), creati-
nine (CREA), urea (U), cholesterol (CHOL), triglycerides 
(TRG), calcium (Ca), chloride (Cl), potassium (K), sodium 
(Na) and phosphorus (P) were measured maximally 4 h after 
collection of the blood samples in serum with an Ortho Clin-
ical  Vitros® 250 Chemistry System (Ortho-Clinical Diag-
nostics, Raritan, NJ, USA), whereas coagulation parameters 
were not determined.
Estrous cycle monitoring
17β-Estradiol was measured in the female rats being in the 
estrus phase of the estrous cycle. To monitor estrous cycles 
in adult female rats, daily vaginal lavages were taken dur-
ing 10 days to track the estrous cycles by vaginal cytology. 
Vaginal lavages were obtained daily between 08:00 and 
09:00 a.m. and examined under a low-power light micro-
scope. Lavages were collected by flushing the entrance of the 
vagina with physiological saline, and a Giemsa–Romanow-
ski stain was used to visualize the cells by optical micros-
copy. The stage of the estrous cycle was determined based 
on the presence of leukocytes (metestrus, diestrus), nucle-
ated epithelial cells (proestrus) and cornified epithelial cells 
(estrus) (Long and Evans 1922; Caligioni 2009). A female 
rat that showed a constant 4- or 5-day vaginal estrous cycle 
was regarded as an animal with a regular estrous cycle. An 
extended estrus was defined as exhibiting cornified cells 
with no leukocytes for three or more days, and an extended 
diestrus was defined as the presence of leukocytes for four 
or more days (Cooper and Goldman 1999).
Hormone measurements
17β-Estradiol blood levels were measured using the Estra-
diol (rat) ELISA (EIA-5774) from DRG Instruments (Mar-
burg, Germany). The intra assay coefficient of variation was 
4.1%, calculated by measuring one rat sample 20 times in 
one test routine. The lower detection limit was < 2.0 pg/mL. 
The cross-reactivity reported by the manufacturer was 4.2% 
for estrone, 3.8% for 17β-estradiol-3-glucuronide and 3.6% 
for 17β-estradiol-3-sulphate. Testosterone blood levels were 
measured using the Testosterone (Rat/Mouse) ELISA (EIA-
5179) from DRG Instruments. The intra assay coefficient of 
variation was 5.3%, calculated by measuring one rat sample 
20 times in one test routine. The lower detection limit was 
< 0.2 ng/mL. The cross-reactivity reported by the manufac-
turer was 69.6% for dihydrotestosterone and 7.4% for dihy-
droxyandrosterone.  T3 blood levels were measured using the 
Total T3 RIA Kit (IM 1699) from Beckman Coulter (Brea, 
CA, USA). The intra assay coefficient of variation was 9.9%, 
calculated by measuring one rat sample 20 times in one test 
routine. The lower detection limit was < 0.75 nmol/L.  T4 
blood levels were measured using the Total T4 RIA Kit (IM 
1447) from Beckman Coulter. The intra assay coefficient of 
variation was 10.2%, calculated by measuring one rat sample 
20 times in one test routine. The lower detection limit was 
< 26 nmol/L.
Urinalysis
In the case of the two 90-day feeding trials, an analysis of 
urine of 16 males and 16 females per group was performed 
at the end of the study. In the combined chronic toxicity/
carcinogenicity study, an analysis of urine of 20 male and 
20 female rats per group was performed at months 3, 6, and 
12; at month 24, urine samples from all surviving animals 
were analysed.
Urine was collected from each individual rat in metabolic 
cages for 16 h. The parameters total protein, glucose, ketone, 
leukocyte number, erythrocyte number, bilirubin, urobilino-
gen, nitrate, and pH were analyzed with  Combur10Test® UX 
test strips (Roche Diagnostics, Mannheim, Germany) and 
semi-quantitatively evaluated by reflectance photometry 
with a Urilux S analyzer (Roche Diagnostics). Osmolar-
ity was measured with the  Advanced® Model 3300 micro-
osmometer from Advanced Instruments (Norwood, MA, 
USA).
Gross necropsy and histopathology
At the end of the study, rats were anaesthetized after a 16- to 
18-h fasting period with 10 mg/kg bw xylazine and 75 mg/kg 
bw ketamine. Blood samples for the corresponding analyses 
were taken from the abdominal aorta. Thereafter, the succes-
sive necropsy of the thoracic cavity, the abdominal cavity, 
the genital organs and the head was performed. Moreover, 
the wet weight of the kidneys, spleen, liver, adrenal glands, 
heart, thymus, uterus, ovaries, testes, epididymides and brain 
of all animals was recorded. Organ samples were stored in 
neutrally buffered 10% formalin, except for the eyes and the 
male reproductive tissues, which were immersed in Bouin’s 
solution. The formalin-fixed tissue samples were washed, 
dehydrated and embedded in paraffin. Thereafter, 4-µm thick 
sections were stained with haematoxylin and eosin for the 
light microscopic examination of the tissue structure.
A complete microscopic examination of the brain (includ-
ing cerebrum, cerebellum and medulla/pons), spinal cord 
(at the cervical, mid-thoracic and lumbar level), pituitary, 
thyroid, parathyroid, thymus, oesophagus, salivary glands, 
stomach, small and large intestines, gut-associated lymphoid 
tissue (GALT), liver, pancreas, kidneys, adrenals, spleen, 
heart, trachea and lungs, aorta, tongue, eyes, Harderian 
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gland, lacrimal gland, ovaries, cervix, vagina, uterus, female 
mammary gland, prostate, testes, seminal vesicles and coag-
ulating gland, epididymides, urinary bladder, mesenteric and 
mandibular lymph nodes, peripheral nerve (sciatic), skeletal 
muscle, femur, sternum with bone marrow, and skin was 
performed.
In-life and necropsy phases were conducted “blind” at the 
Slovak Medical University (Bratislava, Slovakia). The group 
allocation was revealed to the histology facility (Wolfgang 
Baumgärtner, University of Veterinary Medicine Hannover, 
Germany) before the start of tissue staining and slide prepa-
rations, and to the pathologist (Roger Alison Ltd., Lampeter, 
UK) before the start of the histopathological examination, 
i.e. histology and histopathology were “non-blind”.
Histology was conducted “non-blind” for operational 
reasons. If histology had been conducted “blind”, all slides 
from all animals would have had to be processed, incurring 
significant penalties in cost and time. “Non-blind” histology 
allowed processing of only control and high dose group ani-
mals, together with macroscopic abnormalities and potential 
target organs. As the histology laboratory was not involved 
in the generation of data, this was not considered to have 
impacted upon the scientific evaluation of the study.
Histopathology was conducted “non-blind” because the 
consensus of opinion among toxicologic pathologists is 
that “blind reading” during the initial evaluation of tissues 
can have a negative impact on both the time it takes to 
accomplish the microscopic evaluation as well as the qual-
ity of the information obtained from the study (Iatropou-
los 1984; Newberne and de la Iglesia 1985; SOTP 1986; 
Prasse et al. 1986; Goodman 1988; House et al. 1992; 
Crissman et al. 2004). “Blind reading” makes the task of 
separating treatment-related changes from normal varia-
tion more difficult and may result in missing subtle lesions. 
Awareness of the treatment group assignment allows the 
pathologist to intensely focus the histopathologic evalu-
ation and to find important, and sometimes subtle, differ-
ences between the tissues of treated and untreated animals. 
“Blind reading” is commonly reserved for targeted review 
of lesions once they have been identified at the primary 
evaluation, particularly in a “Pathology Working Group”. 
In addition, all major published data on background 
lesions of rats from toxicity and carcinogenicity studies 
has been derived from “non-blind reading”. Reading the 
present series of studies “blind” would have significantly 
decreased the comparability of the findings to published 
data.
The resulting tissue sections were stained by hematoxy-
lin and eosin at the above-mentioned histology facility. 
Histopathology examinations were performed in com-
pliance with the principles of Good Laboratory Practice 
(GLP). The PathData V. 6.2d2 computer system was used 
for the recording and reporting of histopathology findings. 
A peer review of the study was conducted at the Test Site 
by Dr. C. Gopinath, Consultant Toxicological Pathologist. 
The histological sections and raw data (final signed histo-
pathology report) will be returned to the Study Director 
for archiving. Other data related to the histopathologi-
cal evaluation of the study will be archived by the study 
pathologist for at least 10 years. No data will be discarded 
after this period without the consent of the Test Facility. In 
the present report, summary tables with all necropsy and 
histopathology findings are presented. The complete his-
topathology reports (Alison 2018a, b, c) can be accessed 
via the internet portal CADIMA (http://www.cadim a.info).
The statistical analysis of the incidence of tumors in the 
combined chronic toxicity/carcinogenicity study was based 
on the principles outlined by Peto et al. (1980). Peto’s 
method corrects for longevity (and hence for the period 
of time at risk) and applies a statistical approach appro-
priate to the cause of death (“context of observation”). 
This statistical analysis was performed on all animals 
from both phases of the study together. Where appropri-
ate, tumors were also grouped for analysis (McConnell 
et al. 1986). The full analysis is presented in the Path-
Data Appendix in the corresponding histopathology report 
(Alison 2018c). Neoplasms were considered statistically 
significant according to the Peto statistical test at p ≤ 0.05 
for rare tumors and at p ≤ 0.01 for common tumors (FDA 
2001). These analyses were performed using the PathData 
software.
Statistical analysis
This section provides a short description of the methods 
used for the statistical analyses presented in this paper, 
with more detailed descriptions of these and some addi-
tionally applied methods given in the Electronic Supple-
mentary Material. A full description of all the statistical 
methods used and the results obtained in the three studies, 
except for the histopathology, is given in the statistical 
reports (Goedhart and van der Voet 2017, 2018a, b, c, d, 
e, f, g, h, i), which can be accessed via the internet. Sta-
tistical analyses were performed separately for the three 
studies, for males and females, and for the four time points 
(3, 6, 12 and 24 months) in the combined chronic toxicity/
carcinogenicity study. Our main interest was to analyse the 
difference between each of the GM maize feeding groups 
and the control feeding groups with the same amount of 
maize.
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Data preparation
All parameters except time of death and pH were trans-
formed to the natural logarithmic scale and then averaged 
to the cage level. This implies that, rather than looking at 
differences between feeding group means, ratios between the 
GM feeds and the corresponding control feed are of interest. 
Since the endpoints uLeu, uHemogl and uKeton had zero 
values, half of the smallest positive value was added to these 
observations before taking the logarithm. Data from rats fed 
diets with non-GM maize in the EU-funded project GRACE 
(http://www.grace -fp7.eu) were used as historical control 
data to set equivalence limits according to the method of van 
der Voet et al. (2017). The GRACE data have been analysed 
before (Schmidt and Schmidtke 2014; Schmidt et al. 2015a, 
b, 2016, 2017; Zeljenková et al. 2014, 2016). More details 
of the data preparation including outlier detection are given 
in the Electronic Supplementary Material.
Summary tables of means and standard deviations (SDs), 
classified by the feeding groups, were prepared on the origi-
nal non-transformed scale. These tables were obtained by 
first calculating cage means and then calculating the sum-
mary statistics. Extended tables with the number of obser-
vations and coefficients of variation (%) are included in the 
statistical reports (Goedhart and van der Voet 2017, 2018b, 
c, d, e, f). In the combined chronic toxicity/carcinogenicity 
study, when measurements were made after 3, 6, 12 and 
24 months, the number of cages per feeding group was 35 for 
the body weights, 20 for the haematology, differential WBC 
and clinical biochemistry data and 10 for the urine data. The 
number of cages per feeding group in the two 90-day feeding 
trials was 8, except for the hormone data with six cages for 
males and eight cages for females.
Mortality after 2 years
Death events of animals were rare up to month 12, with 
at most 3 dead animals per group of 50. Therefore, only 
the mortality rates at 24 months were statistically analysed. 
Only the 50 animals per sex and feeding group that were 
part of the 2-year cohort were statistically analysed, because 
the other 20 animals were sacrificed after 1 year. Fitting a 
beta-binomial regression model (Williams 1982) by means 
of maximum likelihood to the number of dead animals in 
each cage as response variable revealed that the estimate 
of the beta-binomial over-dispersion parameter equals its 
bounded value of 0.0001 for both males and females. This 
indicates that there was no over-dispersion and, therefore, 
the ordinary logistic model (McCullagh and Nelder 1989) 
was used to analyse the number of dead animals per cage. 
After allowing for differences between blocks, one-sided 
pairwise Wald tests were performed for the one-sided null 
hypothesis that the mortality probability of a GM feed is 
equal to or smaller than the mortality probability of the non-
GM control feed. Mortality was also analysed by survival 
analysis using the procedures KAPLANMEIER, RSTEST, 
RPROPORTIONAL and RPHFIT and direct programming 
in GenStat 18 (VSN International 2015).
Growth curves and feed consumption
For each individual rat, growth curves were fitted to the 
observed weights for restricted periods of time. For the 
data up to 13 weeks (3 months), an exponential growth 
curve A + B exp(− Week) with growth rate  was fitted 
to the observed weights. For the data between weeks 13 
and 27 (6 months), and separately for the data between 
weeks 27 and 52 (12 months), a simple linear regression, 
Weight =  +  Week , was fitted to the observed weights, 
and the growth rate was defined as  = log() . In general, the 
growth curves fitted very well and it was, therefore, decided 
to only analyse the estimated growth rates  , further called 
growth rate, and the final weights observed after week 13, 
27 and 52. The latter are further called Weight_13 (or just 
BodyWeight in the two 90-day feeding trials), Weight_27 
and Weight_52. No general growth curves could be fitted 
for the data between weeks 53 and 104 (24 months) in the 
combined chronic toxicity/carcinogenicity study, and, there-
fore, only the final weights for those animals that survived 
for 24 months, further called Weight_104, were statistically 
analysed.
Equivalence and difference tests of quantitative endpoints
Traditionally, the first step in the statistical analysis of toxi-
cological data is to determine if there are statistically sig-
nificant differences between groups (difference tests). Only 
in a second step of the classical approach, the toxicological 
relevance of such statistically significant differences is inter-
preted in the light of historical control data. In this paper, 
the “toxicological relevance” question is directly addressed 
using equivalence tests. This procedure has a known prob-
ability of a Type 1 error (failing to find a potential relevant 
difference). In contrast, the traditional two-step approach has 
an unknown probability of failing to find a potential relevant 
difference because such a difference might not be statisti-
cally significant due to lack of precision. Thus, the one-step 
approach, which always considers the historical control data 
(irrespective of the result of the difference test), is preferred 
to the two-step approach. This is also in line with the EFSA 
recommendation (EFSA 2011c) stating that less emphasis 
should be placed on the reporting of statistical significance 
and more on statistical point estimation and associated inter-
val estimations as more information can be presented using 
the latter.
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Equivalence testing was introduced for GM safety assess-
ment for compositional data in the EFSA guidance for risk 
assessment of food and feed from GM plants (EFSA 2011b). 
In the context of 90-day feeding studies in rodents, EFSA 
(2014) recognized the potential advantages of equivalence 
testing and recommended further investigation. In response 
to this issue, an equivalence test was developed in the course 
of the G-TwYST project (see van der Voet et al. [2017] for a 
full description and explanation of the approach). This test 
compares the difference between a test (T) and a control (C) 
feed, obtained simultaneously in a current study, to the typi-
cal differences between reference (R) feeds obtained in one 
or more historical studies. The equivalence test corrects for 
between-study differences, and the within-study variation 
between references R, along with the residual variation, is 
used to set equivalence limits for the difference between T 
and C in the current study. The so-called distribution wise 
equivalence (DWE) criterion is used in this test. The equiva-
lence test employs the concept of desired power (here chosen 
as 95%) in a simplified situation, where there is no between-
reference variation, where the historical and current studies 
have the same residual variance, and where the current study 
is assumed to have a sample size as approved by a regula-
tor. Here we assumed regulatory sample sizes equal to the 
replication, i.e. the number of cages for most parameters in 
the current studies, e.g. 8 for the 90-day studies.
A critical factor is that the equivalence test of van der 
Voet et al. (2017) requires historical control data. It is 
assumed that the natural variability in results between non-
GM reference groups can be estimated from previous stud-
ies in the same experimental facility. For the 3-month data 
in the three feeding trials, the GRACE non-GM reference 
data described in section “Data preparation” serve this 
purpose. For the data obtained after 6, 12 and 24 months, 
no corresponding reference data were available. Variance 
components between and within reference feeds were not 
much different between 3 and 6 months in the 90-day feed-
ing trial with the GM maize at an inclusion rate of 11 and 
33%, and, therefore, the 3-month GRACE data were still 
used as a reference for the 6-month data. The data varia-
tion was generally larger after 12 and 24 months; there-
fore, no equivalence tests are reported here for these data, 
and the assessment of the biological relevance was in these 
cases based on the expert opinion of the study coordinator. 
Details of the equivalence test calculations are given in the 
Electronic Supplementary Material.
The equivalence test results in a confidence interval for 
the so-called equivalence limit scaled difference (ELSD), 
which can be used both for difference and for equivalence 
testing. The hypothesis of no difference is rejected in case 
the interval does not contain zero, while the non-equiva-
lence hypothesis is rejected in favour of an “equivalence” 
conclusion when the interval fully lies inside the interval 
(− 1, 1). When the ELSD point estimate is between − 1 and 
+ 1, but one or both of the confidence limits lie outside this 
interval, the conclusion, in the terminology of EFSA, is 
that “equivalence is more likely than not”. “Non-equiva-
lence is more likely than not” when the ELSD point esti-
mate is lower than − 1 or higher than + 1. As a further help 
for interpretation of the ELSD graphs, it can be noted that 
confidence intervals for ELSD will become wider when 
the within-group variation in the current study is higher 
than in the historical data. Such higher variation may be 
treatment-induced or just the consequence of a lower ana-
lytical precision in the current study.
Classical statistical methods for continuous data were 
applied in line with OECD and EFSA approaches, and 
very similar to the approaches followed in the GRACE 
project (Schmidt and Schmidtke 2014; Schmidt et  al. 
2015a, b). OECD Test Guidelines require numerical 
results to be evaluated by an appropriate and acceptable 
statistical method, but give no further guidance on statisti-
cal analysis. More detailed guidance, although strictly only 
meant for chronic and carcinogenicity studies of single 
compounds, not of complex whole foods, is provided in 
chapter 4 of the OECD Guidance Document 116 (OECD 
2014). A classical analysis of variance was performed on 
the cage means after log-transforming the data. This was 
done in the statistical program R. The analysis of variance 
was performed according to the randomized block design 
employing the model “Block + Treatment”, where Treat-
ment defines the five feeding groups. For details see the 
Electronic Supplementary Material. Significance results of 
the different tests comparing GM maize-fed groups with 
the control group have been indicated in the tables with 
means and SDs.
All tests were performed by comparing two-sided 95% 
confidence intervals to values representing equivalence lim-
its or strict equality (no difference).
Stakeholder involvement and access to data
A key characteristic of the G-TwYST project was to allow 
for the involvement of a broad range of stakeholders and 
to ensure transparency of the research conducted, includ-
ing access to the data. Stakeholder consultations were con-
ducted not just on the results but also a priori on the study 
plans. The main stakeholder groups targeted were compe-
tent authorities, industry, civil society organizations, and 
researchers interested or experienced in animal feeding 
studies with GM food/feed. The geographical focus was on 
Europe.
In a first round, the draft study plans were subjected to 
a stakeholder consultation. The comments on these drafts, 
which had been received in the course of a stakeholder 
workshop and afterwards in writing, were discussed by the 
1103Archives of Toxicology (2019) 93:1095–1139 
1 3
study team and taken into account when finalizing the study 
plans. As a result of the discussions during the stakeholder 
workshop, a 90-day feeding trial with a GM maize inclu-
sion rate of up to 50%, as well as an analysis of hormone 
levels in blood samples of male (testosterone,  T3 and  T4) and 
female rats (17β-estradiol,  T3 and  T4) fed the GM maize at 
inclusion rates of 11 and 33% were performed. Study team 
members answered the stakeholder comments and questions 
in a written form, so that the stakeholders could verify if and 
how their comments had been taken into consideration and 
understand the underlying reasons for doing so.
In a similar way, the draft results and conclusions were 
subjected to stakeholder scrutiny. This final round included 
three subsequent steps, one workshop and two rounds of 
written comments: one round of written comments focused 
on the results of the 90-day studies. The stakeholder work-
shop and another round of written comments focused on 
the combined chronic toxicity and carcinogenicity study. To 
facilitate the consultation process, the documents includ-
ing all full-length statistical as well as histopathology draft 
reports and draft interpretations were made available to reg-
istered participants that had signed a Non-Disclosure Agree-
ment. Again, all stakeholder comments were considered 
when finalizing interpretation and conclusions, and written 
responses were prepared by the study team.
Maximum transparency of the process was established by 
publishing on the project website all stakeholder comments, 
as well as the written responses of the study team members 
in comprehensive consultation reports alongside with the 
draft and revised study plan (http://www.g-twyst .eu).
For each consultation round more than 700 stakehold-
ers were invited by e-mail. Stakeholder participants were 
not selected in any way: all interested stakeholder repre-
sentatives could participate. Overall 70 stakeholders from 19 
countries participated in one or more consultation stages. A 
total of 158 stakeholder comments were received in written 
form and responded to by the study team. In each consulta-
tion stage, representatives of all main stakeholder groups 
targeted were involved and actively contributed.
Access to the raw data
In line with the G-TwYST transparency policy any interested 
person will have access to the raw data obtained in the frame 
of the G-TwYST project, including the clinical, ophthalmo-
logical, body weight, haematology, clinical biochemistry, 
organ weight, necropsy and histopathology data presented 




The main components of the diets are listed in Table 1 of the 
Electronic Supplementary Material. The amount of soybean 
meal was restricted to a level of 5% in all diets, since soy-
bean meal contains high amounts of isoflavones, which per 
se induce estrogenic effects (Eisenbrand 2008) and could, 
therefore, interfere with the outcome of the feeding trials. 
Soybean meal is also an important protein source; to com-
pensate the lower delivery of proteins by soybean meal, a 
rice protein concentrate was included in all diets.
The compositional analysis of the diets used in the three 
feeding trials performed with the GM maize NK603 in the 
course of the G-TwYST project can be accessed via the 
internet portal CADIMA (http://www.cadim a.info). Briefly, 
six batches of all diets were prepared and batches 1, 3 and 5 
of all diets were analyzed. All batches showed similar lev-
els of the proximates (ash, total carbohydrates, fat, protein), 
starch, fibres, amino acids, fatty acids, minerals, vitamins, 
sugars, anti-nutrients and other secondary metabolites, 
except for the phenylpropanoids caffeic acid, ferulic acid 
and p-coumaric acid as well as the B vitamin niacin and 
the isoflavones daidzin and glycitin, which were nominally 
higher in the batch 1 than in the batches 3 and 5 of all diets. 
These differences are due to the fact that Covance analysed 
the bound + free phenylpropanoids in batch 1, while SGS 
analysed the free phenylpropanoids in batches 3 and 5. 
Moreover, the levels of the B vitamin niacin and the isofla-
vones daidzin and glycitin were also higher in batch 1 than 
in batches 3 and 5, which is due to some differences in the 
methodology applied by the different labs involved. None of 
the detected differences were considered to affect the health 
of the rats in any way. The levels of the above-mentioned 
proximates and compounds in the separate batch of diets 
prepared for the 90-day feeding trial with a GM maize inclu-
sion rate of up to 50% were similar to those measured in the 
batch 3 of all diets, which were used for the 90-day feeding 
trial with a GM maize inclusion rate of 11 and 33%.
Low and similar amounts of polychlorinated dibenzo-
p-dioxins and dibenzofurans, polychlorinated biphenyls, 
polycyclic aromatic hydrocarbons, mycotoxins and nitrosa-
mines were detected in all analyzed diet batches. Residues of 
the pesticides 2-phenylphenol, cypermethrin, deltamethrin, 
tetramethrin, ethoxyquin, piperonyl butoxide, pirimiphos-
methyl, N-desethyl-pirimiphos-methyl and propiconazole 
were detected in all diets. The glyphosate levels in the 
near-isogenic non-GM maize (Pioneer 8906) kernels, as 
well as in the untreated and Roundup-treated GM maize 
NK603 (Pioneer 8906 R) kernels were ≤ 16 ppb, while the 
glyphosate levels ranged between about 30 and 140 ppb in 
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batches 1, 3 and 5 of all diets, including the control diet 
(Table 3, Electronic Supplementary Material). Glyphosate 
levels were below the limit of detection in the 50% control, 
11% NK603, 50% NK603, 11% NK603 + Roundup and 50% 
NK603 + Roundup diets, while glyphosate was detected in 
the 33% control and 33% NK603 + Roundup diets used for 
the 90-day feeding trial with the GM maize NK603 at an 
inclusion rate of up to 50% (Table 4, Electronic Supple-
mentary Material). The amount of the major glyphosate 
metabolite aminomethylphosphonic acid (AMPA) in all 
diets was below the limit of quantification (< 100 ppb). The 
detected levels of contaminants and pesticide residues were 
well below regulatory limits and, therefore, none of them 
were considered to affect the health of the rats in any way.
As expected, the NK603 event was detected in all ana-
lyzed batches of the diets containing 11, 33 or 50% of the 
GM maize NK603 using a highly specific PCR assay ampli-
fying a DNA fragment overlapping the transition between 
inserted and genomic maize DNA in the NK603 maize 
(Tables 3, 4, Electronic Supplementary Material). Moreover, 
the NK603 event was not detected in batch 1 of the control 
diet, whereas the batches 3 and 5 of the control diets as well 
as the separate control diet batch with a 50% maize inclusion 
rate contained non-quantifiable traces of the NK603 event 
(Tables 3, 4, Electronic Supplementary Material). These 
NK603 maize traces were considered not to influence the 
feeding trials in any way.
Following irradiation, microorganisms such as coliforms, 
Enterobacteriaceae, yeast and molds were not detected in 
the diets.
90‑day feeding trial with the GM maize NK603 
at an inclusion rate of 11 and 33% in the diets
The study design is shown in Table  1. There was one 
unscheduled death: a male rat fed the 33% NK603 diet was 
sacrificed moribund on day 51 due to a malignant lym-
phoma, which was considered not to be treatment-related, 
since it was only observed in 1 out of 16 young animals 
having been fed the diet for less than 2 months. The rat 
body weights as well as the feed consumption during the 
90-day feeding period in all five experimental groups are 
shown in Figs. 1 and 2. Statistically significant differences 
were observed in 5 of the 24 comparisons regarding final 
body weight, growth rate and feed consumption in male 
and female rats over four NK603 groups. The equivalence 
tests (in which the data obtained in the present study were 
compared with the historical control data of the animal test-
ing facility, i.e. the data obtained from the GRACE pro-
ject feeding trials) showed “equivalence” for 22 of the 24 
comparisons, i.e. ELSD intervals were in the equivalence 
area between − 1 and + 1. The upper ELSD confidence limit 
was outside the interval [− 1, + 1] for the growth rate in 
female rats fed the 11% GM maize NK603 or the 33% GM 
maize NK603 + Roundup diet; therefore, in these two cases 
the appropriate conclusion is “equivalence more likely than 
not” (Fig. 2b).
The data on the haematological parameters meas-
ured in the blood samples of the male and female rats are 
shown in Table 2 and Fig. 2. The MCHC was significantly 
lower in male rats fed the 11% NK603 diet and the 11% 
NK603 + Roundup (with a Roundup application during cul-
tivation) diet when compared to the control value based on 
the 95% confidence interval. The percentage lymphocytes 
(determined in the differential leukocyte analysis) was sig-
nificantly lower and the percentage neutrophils significantly 
higher in male rats fed the 33% NK603 diet. Apart from 
these four statistically significant differences in male rats, 
no significant differences were observed in the case of the 
other 108 comparisons with the control group involving the 
14 haematological parameters in male and female rats over 
4 NK603 groups. The equivalence tests showed “equiva-
lence” in 89 of the 104 comparisons with the control group 
for 13 haematological parameters (note that there were no 
historical control data for 1 parameter, LYMR) in male and 
female rats over 4 NK603 groups, and “equivalence more 
likely than not” in the case of the remaining 15 comparisons. 
One or both ELSD confidence limits were outside the inter-
val [− 1, + 1] for the percentage lymphocytes in the male 
rats fed with any of the 4 GM maize diets (Fig. 2a), for 
Table 1  Study design of the 
90-day feeding trial with 
the GM maize NK603 at an 
inclusion rate of 11 and 33% in 
the diet
Group Content in the diet (%) Number of animals
Near-isogenic 
non-GM
NK603 NK603 + roundup Males Females
1 33 0 0 16 16
2 22 11 0 16 16
3 0 33 0 16 16
4 22 0 11 16 16
5 0 0 33 16 16
Sentinels 6 6
Total 86 86
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HCT and the percentage lymphocytes in the female rats fed 
with any of the 4 GM maize diets, for RBC in female rats 
fed the 33% NK603 diet and for the percentage eosinophils 
in female rats fed the 11% NK603 + Roundup and the 33% 
NK603 + Roundup diets (Fig. 2b). These were all cases in 
which the within-group data variance was larger than the 
within-variance of the historical control data.
The data on the clinical biochemical parameters meas-
ured in the blood samples of the male and female rats are 
shown in Table 3 and Fig. 2. In male rats, K levels were 
significantly higher in animals fed the 33% NK603 diet, ALT 
activity was significantly lower and ALB, TP, CREA and 
K levels were significantly higher in animals fed the 11% 
NK603 + Roundup diet and ALP activity was significantly 
higher in animals fed the 33% NK603 + Roundup diet when 
compared to the corresponding control diets. In female rats, 
GLU and Cl levels were significantly lower and the TAG 
level significantly higher if compared to the corresponding 
control values. Apart from these 10 significances, the other 
110 comparisons of the 15 clinical biochemical parameters 
with the control group in male and female rats over four 
NK603 groups showed no statistically significant differ-
ences. The equivalence tests showed “equivalence” for all 
120 comparisons involving clinical biochemical parameters, 
i.e. all ELSD intervals were fully inside the interval [− 1, 
+ 1] (Fig. 2a, b).
The testosterone,  T3 and  T4 levels in the serum of male 
rats are shown in Table 4. The testosterone and  T3 levels in 
the four groups fed the NK603 diet were not significantly 
different from those in the corresponding control group, 
whereas the  T4 level was significantly lower in the group fed 
the 33% NK603 diet if compared to the control group. The 
17β-estradiol,  T3 and  T4 levels in the serum of female rats 
are shown in Table 5. The 17β-estradiol levels in the four 
Fig. 1  Male and female rat body 
weight development (upper 
charts) and feed consumption 
(lower charts) during the 90-day 
feeding trial with GM maize 
NK603 at an inclusion rate of 
11 and 33% in the diet
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groups fed the NK603 diet were significantly lower than that 
in the control group. The  T3 levels in the four groups fed the 
NK603 diet were not significantly different from that in the 
control group, while the  T4 level was significantly lower in 
the 33% NK603 + Roundup group than in the control group.
The urinalysis data are summarized in the statistical report 
by Goedhart and van der Voet (2017). The urine pH was sig-
nificantly lower in male rats fed the 33% NK603 and 33% 
NK603 + Roundup diets than in the control group, while the 
ketone level was significantly lower in female rats fed the 
33% NK603 + Roundup diet than in the control group. Apart 
from these 3 significances, the other 45 comparisons with 
the control group involving six urinalysis parameters in male 
and female rats over 4 NK603 groups showed no significant 
differences.
The relative organ weights in male and female rats are 
shown in Table 6 and Fig. 2. The relative thymus weight in 
male rats fed the 11% NK603 + Roundup diet was significantly 
higher than that in the control group. In female rats, the rela-
tive adrenal gland weight in the groups fed the 11% NK603, 
Fig. 2  Equivalence testing of the parameters measured in male 
(a) and female rats (b) fed the diets with 11% GM maize NK603 
(NK11−), 33% GM maize NK603 (NK33−), 11% GM maize 
NK603 + Roundup (NK11+) or 33% GM maize NK603 + Roundup 
(NK33+) versus the rats fed the control diet. For estimates (square 
symbols) left of zero, the parameter in rats fed the GM maize feed 
has a smaller mean than that in rats fed the control feed. Endpoints 
labelled with a yellow background have a larger residual variance 
compared to the historical studies (variance ratio > 150%). Fuchsia 
coloured symbols denote a significant difference
◂
Table 2  Haematology parameters (mean ± SD) in the serum of male and female Wistar Han RCC rats in the 90-day feeding trial with GM maize 
NK603 at an inclusion rate of 11 and 33% in the diet
Eight cages/group, two rats/cage
*Statistically significant difference to the control value based on the 95% confidence interval
Parameter 33% Control 11% NK603 33% NK603 11% NK603 + Roundup 33% 
NK603 + Roundup
Male rats
 WBC  (109/L) 9.10 ± 1.92 8.85 ± 1.58 9.42 ± 1.63 9.75 ± 1.22 9.57 ± 1.04
 RBC  (1012/L) 7.79 ± 0.30 7.77 ± 0.44 7.77 ± 0.27 7.67 ± 0.35 7.83 ± 0.20
 HGB (g/dL) 14.6 ± 0.41 14.7 ± 0.29 14.7 ± 0.44 14.4 ± 0.55 14.8 ± 0.18
 HCT (%) 42.4 ± 1.21 42.8 ± 1.96 43.0 ± 1.40 42.4 ± 1.60 43.2 ± 0.84
 MCV (fL) 54.4 ± 1.07 55.2 ± 1.44 55.4 ± 1.16 55.4 ± 1.38 55.1 ± 0.63
 MCH (pg) 18.8 ± 0.46 18.7 ± 0.52 19.0 ± 0.69 18.8 ± 0.78 19.0 ± 0.45
 MCHC (g/dL) 34.6 ± 0.28 33.9 ± 0.94* 34.2 ± 0.78 33.9 ± 0.59* 34.4 ± 0.76
 PLT  (109/L) 842 ± 75 792 ± 120 862 ± 125 851 ± 83 847 ± 115
 LYMR (%) 73.0 ± 3.74 72.5 ± 4.97 70.9 ± 5.89 72.0 ± 3.41 73.4 ± 5.06
 LYMA  (103/µL) 6.64 ± 1.55 6.42 ± 1.24 6.68 ± 1.34 7.00 ± 0.70 7.04 ± 1.09
 Lymphocytes (%) 71.4 ± 6.45 68.1 ± 6.48 65.8 ± 5.86* 69.8 ± 6.53 70.6 ± 6.28
 Neutrophils (%) 25.7 ± 6.58 28.8 ± 7.01 30.5 ± 5.17* 26.8 ± 6.83 26.4 ± 6.60
 Monocytes (%) 1.50 ± 0.46 1.66 ± 0.44 1.78 ± 0.92 1.53 ± 0.41 1.31 ± 0.42
 Eosinophils (%) 1.44 ± 0.58 1.41 ± 0.72 1.84 ± 1.32 1.91 ± 0.90 1.72 ± 0.78
Female rats
 WBC  (109/L) 5.52 ± 1.48 5.37 ± 0.97 6.06 ± 1.16 4.86 ± 0.70 5.43 ± 1.26
 RBC  (1012/L) 6.73 ± 0.22 6.72 ± 0.55 6.87 ± 0.17 6.81 ± 0.50 6.66 ± 0.30
 HGB (g/dL) 13.7 ± 0.45 13.6 ± 1.03 14.1 ± 0.18 13.8 ± 0.81 13.6 ± 0.65
 HCT (%) 39.4 ± 1.09 39.1 ± 3.29 40.5 ± 0.95 39.9 ± 2.57 39.6 ± 1.81
 MCV (fL) 58.7 ± 1.40 58.2 ± 1.79 59.1 ± 1.03 58.7 ± 1.63 59.6 ± 1.32
 MCH (pg) 20.4 ± 0.69 20.2 ± 0.54 20.6 ± 0.44 20.4 ± 0.84 20.4 ± 0.62
 MCHC (g/dL) 34.8 ± 0.83 34.7 ± 0.75 34.8 ± 0.64 34.7 ± 0.93 34.3 ± 0.47
 PLT  (109/L) 902 ± 113 825 ± 144 901 ± 91 813 ± 100 904 ± 94
 LYMR (%) 75.2 ± 5.81 75.1 ± 3.52 77.5 ± 3.52 76.6 ± 4.92 77.1 ± 4.96
 LYMA  (103/µL) 4.22 ± 1.37 4.04 ± 0.69 4.69 ± 0.91 3.71 ± 0.69 4.15 ± 0.97
 Lymphocytes (%) 69.2 ± 5.98 69.5 ± 6.24 70.4 ± 3.79 71.9 ± 5.15 71.1 ± 4.08
 Neutrophils (%) 28.1 ± 4.73 28.5 ± 5.76 26.8 ± 4.46 26.1 ± 5.02 26.1 ± 4.18
 Monocytes (%) 1.53 ± 0.76 1.12 ± 0.65 1.44 ± 0.83 1.12 ± 0.38 1.25 ± 0.57
 Eosinophils (%) 1.16 ± 1.20 0.91 ± 0.71 1.31 ± 0.94 0.88 ± 1.03 1.56 ± 0.98
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Table 3  Clinical biochemistry parameters (mean ± SD) in the serum of male and female Wistar Han RCC rats in the 90-day feeding trial with 
GM maize NK603 at an inclusion rate of 11 and 33% in the  diet1
Eight cages/group, two rats/cage
*Statistically significant difference to the control value based on the 95% confidence interval
Parameter 33% Control 11% NK603 33% NK603 11% NK603 + Roundup 33% NK603 + Roundup
Male rats
 ALP (µkat/L) 1.25 ± 0.14 1.28 ± 0.18 1.27 ± 0.14 1.25 ± 0.13 1.44 ± 0.19*
 ALT (µkat/L) 0.56 ± 0.04 0.57 ± 0.06 0.55 ± 0.08 0.50 ± 0.06* 0.56 ± 0.08
 AST (µkat/L) 2.40 ± 0.60 2.30 ± 0.47 2.23 ± 0.36 2.12 ± 0.38 2.22 ± 0.45
 ALB (g/L) 36.4 ± 0.81 36.6 ± 1.77 36.9 ± 0.79 37.8 ± 0.99* 36.4 ± 1.30
 TP (g/L) 64.4 ± 1.13 65.1 ± 2.32 65.0 ± 1.08 66.2 ± 1.66* 64.6 ± 1.36
 GLU (mmol/L) 5.38 ± 0.85 5.34 ± 0.82 5.02 ± 0.69 5.15 ± 0.36 5.49 ± 0.53
 CHOL (mmol/L) 2.05 ± 0.23 2.01 ± 0.27 2.02 ± 0.22 1.94 ± 0.19 2.04 ± 0.17
 TAG (mmol/L) 1.02 ± 0.25 1.10 ± 0.14 1.05 ± 0.33 1.03 ± 0.31 1.09 ± 0.39
 CREA (mmol/L) 40.1 ± 2.09 41.5 ± 4.78 40.8 ± 3.61 43.8 ± 4.66* 41.9 ± 4.15
 UREA (mmol/L) 5.13 ± 0.32 4.90 ± 0.55 4.99 ± 0.28 4.88 ± 0.43 4.96 ± 0.50
 Ca (mmol/L) 2.40 ± 0.04 2.40 ± 0.03 2.41 ± 0.06 2.41 ± 0.05 2.39 ± 0.04
 Cl (mmol/L) 102 ± 1.33 102 ± 1.19 102 ± 1.03 102 ± 0.70 102 ± 1.22
 K (mmol/L) 4.99 ± 0.23 5.09 ± 0.37 5.25 ± 0.20* 5.22 ± 0.31* 5.11 ± 0.24
 Na (mmol/L) 145 ± 1.65 145 ± 1.46 145 ± 1.16 146 ± 1.12 145 ± 1.39
 P (mmol/L) 2.37 ± 0.31 2.44 ± 0.19 2.50 ± 0.15 2.41 ± 0.16 2.31 ± 0.18
Female rats
 ALP (µkat/L) 0.58 ± 0.14 0.58 ± 0.06 0.65 ± 0.07 0.58 ± 0.07 0.58 ± 0.10
 ALT (µkat/L) 0.47 ± 0.06 0.42 ± 0.04 0.53 ± 0.12 0.45 ± 0.13 0.42 ± 0.08
 AST (µkat/L) 2.30 ± 0.67 2.22 ± 0.34 2.33 ± 0.25 2.21 ± 0.53 2.37 ± 0.44
 ALB (g/L) 42.5 ± 3.53 41.5 ± 2.48 44.6 ± 2.71 44.1 ± 2.64 43.9 ± 2.84
 TP (g/L) 68.7 ± 3.38 67.2 ± 2.90 71.0 ± 2.55 70.9 ± 2.41 70.5 ± 2.97
 GLU (mmol/L) 5.19 ± 0.35 5.12 ± 1.18 4.40 ± 0.68* 5.05 ± 1.12 5.62 ± 1.03
 CHOL (mmol/L) 1.91 ± 0.21 2.05 ± 0.28 2.01 ± 0.28 2.00 ± 0.25 1.99 ± 0.34
 TAG (mmol/L) 0.52 ± 0.13 0.62 ± 0.20 0.65 ± 0.09* 0.60 ± 0.12 0.50 ± 0.39
 CREA (mmol/L) 40.9 ± 2.43 42.0 ± 2.84 42.9 ± 3.98 40.8 ± 5.06 41.9 ± 5.67
 UREA (mmol/L) 5.86 ± 0.35 5.94 ± 0.85 5.32 ± 0.67 5.29 ± 0.64 5.59 ± 0.57
 Ca (mmol/L) 2.47 ± 0.07 2.45 ± 0.04 2.49 ± 0.04 2.50 ± 0.05 2.49 ± 0.05
 Cl (mmol/L) 102 ± 1.03 102 ± 1.54 101 ± 1.06* 102 ± 1.15 102 ± 1.88
 K (mmol/L) 4.45 ± 0.22 4.46 ± 0.20 4.52 ± 0.29 4.54 ± 0.21 4.70 ± 0.33
 Na (mmol/L) 145 ± 1.94 144 ± 1.22 145 ± 1.16 145 ± 1.79 145 ± 2.68
 P (mmol/L) 2.04 ± 0.23 1.96 ± 0.23 2.15 ± 0.36 1.93 ± 0.21 1.96 ± 0.22
Table 4  Testosterone,  T3 and 
 T4 levels (mean ± SD) in the 
serum of male Wistar Han RCC 
rats in the 90-day feeding trial 
with GM maize NK603 at an 
inclusion rate of 11 and 33% in 
the diet
Six cages/group, two rats/cage
*Statistically significant difference to the control value based on the 95% confidence interval





 Testosterone (ng/mL) 2.58 ± 0.88 2.78 ± 1.64 1.97 ± 1.12 3.03 ± 1.93 2.17 ± 0.56
 T3 (nmol/L) 0.75 ± 0.06 0.82 ± 0.14 0.74 ± 0.09 0.75 ± 0.09 0.81 ± 0.08
 T4 (nmol/L) 55.2 ± 4.74 54.0 ± 5.40 48.7 ± 3.65* 55.1 ± 3.77 53.4 ± 5.29
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33% NK603 and the 11% NK603 + Roundup diets, the relative 
ovary weight in the animals fed the 11% NK603 and the 33% 
NK603 + Roundup diets, as well as the relative spleen weight 
in rats fed the 11% NK603 + Roundup diet were significantly 
lower when compared to the corresponding control groups. 
Apart from these 6 significances, the other 66 comparisons 
with the control group involving the 10 relative organ weights 
in male and female rats over 4 NK603 groups showed no sig-
nificant differences. The equivalence tests showed that one or 
both ELSD confidence limits, but not the point estimates, were 
outside the interval [− 1, + 1] for the relative kidney weight in 
female rats fed the 11% NK603 and the 33% NK603 diets as 
well as for the relative uterus weight in the animals fed the 33% 
NK603 + Roundup diet (Fig. 2a, b). In these three cases, the 
conclusion is, therefore, “equivalence more likely than not”, 
whereas in the case of all other 69 comparisons with the con-
trol group involving the 10 organ weight parameters in male 
and female rats over three NK603 groups the conclusion is 
“equivalence”.
The summary tables with all necropsy findings observed 
in male and female rats are listed in the Supplementary 
Electronic Material’s Table 5. There were no treatment-
related necropsy findings following the feeding of NK603 or 
NK603 + Roundup to rats for 90 days. The summary tables 
Table 5  17β-Estradiol,  T3 and  T4 levels (mean ± SD) in the serum of female Wistar Han RCC rats in the 90-day feeding trial with GM maize 
NK603 at an inclusion rate of 11 and 33% in the diet
Eight cages/group, two rats/cage
*Statistically significant difference to the control value based on the 95% confidence interval
Parameter 33% Control 11% NK603 33% NK603 11% NK603 + Roundup 33% NK603 + Roundup
Male rats
 17β-Estradiol (pg/mL) 7.74 ± 4.51 4.98 ± 3.45* 4.63 ± 1.35* 5.04 ± 2.08* 4.64 ± 1.29*
 T3 (nmol/L) 0.76 ± 0.16 0.77 ± 0.12 0.69 ± 0.08 0.73 ± 0.13 0.63 ± 0.12
 T4 (nmol/L) 34.2 ± 7.90 31.0 ± 8.50 34.0 ± 11.40 37.8 ± 9.00 25.4 ± 8.50*
Table 6  Relative organ weights in male and female Wistar Han RCC rats in the 90-day feeding trial with GM maize NK603 at an inclusion rate 
of 11 and 33% in the diet
*Statistically significant difference to the control value based on the 95% confidence interval
Organ Relative organ weights (organ weight/body weight × 100)
33% Control 11% NK603 33% NK603 11% NK603 + Roundup 33% NK603 + Roundup
Male rats
 Adrenal glands 0.014 ± 0.001 0.013 ± 0.002 0.013 ± 0.002 0.013 ± 0.002 0.013 ± 0.001
 Brain 0.49 ± 0.04 0.48 ± 0.03 0.51 ± 0.02 0.51 ± 0.03 0.49 ± 0.05
 Epididymides 0.27 ± 0.02 0.26 ± 0.01 0.28 ± 0.02 0.27 ± 0.02 0.27 ± 0.03
 Heart 0.23 ± 0.01 0.24 ± 0.01 0.24 ± 0.01 0.24 ± 0.02 0.23 ± 0.01
 Kidneys 0.52 ± 0.04 0.52 ± 0.03 0.54 ± 0.03 0.55 ± 0.04 0.52 ± 0.04
 Liver 2.16 ± 0.10 2.19 ± 0.13 2.24 ± 0.13 2.24 ± 0.10 2.17 ± 0.04
 Spleen 0.18 ± 0.02 0.19 ± 0.01 0.18 ± 0.02 0.19 ± 0.02 0.18 ± 0.02
 Testes 0.81 ± 0.08 0.80 ± 0.05 0.82 ± 0.04 0.83 ± 0.81 0.68 ± 0.06
 Thymus 0.09 ± 0.01 0.10 ± 0.02 0.10 ± 0.02 0.10 ± 0.02* 0.10 ± 0.02
Female rats
 Adrenal glands 0.031 ± 0.003 0.028 ± 0.002* 0.028 ± 0.002* 0.028 ± 0.003* 0.029 ± 0.002
 Brain 0.84 ± 0.06 0.85 ± 0.83 0.83 ± 0.05 0.83 ± 0.05 0.82 ± 0.02
 Heart 0.32 ± 0.02 0.31 ± 0.04 0.31 ± 0.02 0.31 ± 0.02 0.32 ± 0.03
 Kidneys 0.60 ± 0.05 0.57 ± 0.05 0.57 ± 0.05 0.58 ± 0.03 0.58 ± 0.03
 Liver 2.44 ± 0.14 2.55 ± 0.19 2.50 ± 0.32 2.53 ± 0.17 2.39 ± 0.08
 Ovaries 0.038 ± 0.003 0.034 ± 0.003* 0.035 ± 0.006 0.036 ± 0.003 0.032 ± 0.001*
 Spleen 0.24 ± 0.02 0.23 ± 0.03 0.24 ± 0.02 0.22 ± 0.02* 0.25 ± 0.02
 Thymus 0.12 ± 0.02 0.12 ± 0.02 0.12 ± 0.03 0.12 ± 0.02 0.12 ± 0.02
Uterus 0.25 ± 0.05 0.26 ± 0.08 0.24 ± 0.05 0.25 ± 0.06 0.31 ± 0.05
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with all histopathological findings observed in male and 
female rats are listed in the Supplementary Electronic Mate-
rial’s Tables 6 and 7, respectively. There were no treatment-
related histopathological findings following the feeding of 
NK603 or NK603 + Roundup to rats for 90 days.
90‑Day feeding trial with the GM maize NK603 
at an inclusion rate of up to 50% in the diets
The study design is shown in Table 7, while the body weight 
and the feed consumption of the rats are shown in Fig. 3a, 
b, respectively, with a summary on group comparisons in 
Fig. 4a–d. The body weight as well as the feed consump-
tion during the 90-day feeding period was significantly 
decreased for male rats fed NK603 at the 50% inclusion rate 
relative to the 50% control diet. The body weight as well as 
the feed consumption of female rats during the 90-day feed-
ing period was significantly increased for female rats fed 
NK603 + Roundup at an inclusion rate of 11% compared to 
the control group with an inclusion rate of 50%. The growth 
rate was significantly increased for female rats fed NK603 at 
an inclusion rate of 50%. Apart from these 5 significances, 
the other 49 comparisons involving the body weight, feed 
consumption and growth rate of male and female rats over 9 
types of comparison (see headers in Fig. 4) showed no sig-
nificant differences. The equivalence tests showed “equiva-
lence” for all 54 comparisons, i.e. all ELSD intervals were 
fully inside the interval [− 1, + 1] (Fig. 4a–d).
The data on the haematological parameters meas-
ured in the blood samples of the male and female rats are 
shown in Table 8 and Fig. 4. In male rats, HGB in the 
group fed the 11% NK603 and the 11% NK603 + Roundup 
diets, PLT in the group fed the 50% NK603 and the 50% 
NK603 + Roundup diets and HCT in the group fed the 11% 
NK603 + Roundup diet were significantly higher than in the 
50% control group, MCV and MCH were significantly lower 
in the group fed the 33% NK603 + Roundup than in the 33% 
control group and MCV and MCH were significantly higher 
in the group fed the 50% NK603 + Roundup diet than in the 
group fed the 33% NK603 + Roundup diet. Moreover, the 
percentage lymphocytes was significantly higher in male rats 
fed the 50% control diet than in the group fed the 33% con-
trol diet. The percentage neutrophils was significantly lower 
in male rats fed the 50% NK603 diet than in the groups fed 
the 50% control diet or the 33% NK603 diet. In female rats, 
RBC was significantly higher and MCV significantly lower 
in the group fed the 33% NK603 + Roundup diet than in the 
group fed the 33% control diet, while PLT was significantly 
lower in the group fed the 50% NK603 diet + Roundup than 
in the group fed the 33% NK603 + Roundup diet. Apart from 
these 14 significances, the other 238 comparisons involving 
the 14 haematological parameters in male and female rats 
over nine types of comparison (see headers in Fig. 4) showed 
no significant differences.
The differential white blood count data in the present 
study were much more variable than the historical control 
data. This indicates that the analytical methods used in the 
current and historical study were not comparable, and there-
fore, the historical data were not considered suitable to be 
used for equivalence tests (see details in Goedhart and van 
der Voet 2018i). The equivalence tests for all 162 compari-
sons involving the remaining 9 haematological parameters 
showed “equivalence”, i.e. all ELSD intervals were fully 
inside the interval [− 1, + 1] (Fig. 4a–d).
The data on the clinical biochemical parameters in 
male and female rats are shown in Table 9 and Fig. 4. 
In male rats, the TP level was lower in the group fed the 
50% control diet than in the group fed the 33% control 
diet, whereas ALB and K levels were significantly higher 
in the group fed the 11% NK603 diet than in the group 
fed the 50% control diet. UREA was significantly lower 
in the group fed the 33% NK603 diet than in the 33% con-
trol group, while it was significantly higher in the 11% 
NK603 + Roundup group than in the 50% control group. 
Table 7  Study design of the 
90-day feeding trial with 
the GM maize NK603 at an 
inclusion rate of up to 50% in 
the diet
Group Content in the diet (%) Number of animals
Near-isogenic 
non-GM
NK603 NK603 + Roundup Males Females
1 33 0 0 16 16
2 0 33 0 16 16
3 0 0 33 16 16
4 50 0 0 16 16
5 39 11 0 16 16
6 0 50 0 16 16
7 39 0 11 16 16
8 0 0 50 16 16
Sentinels 6 6
Total 134 134
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Fig. 3  Male and female rat body weight development (upper charts) and feed consumption (lower charts) during the 90-day feeding trial with 
GM maize NK603 at an inclusion rate of up to 50% in the diet
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Fig. 4  a Equivalence testing of 50% GM maize feeds versus the cor-
responding 50% non-GM control maize feed for male rats. b Equiv-
alence testing of 50% maize feeds versus the corresponding 33% 
maize feeds and of 33% GM maize feeds versus the 33% non-GM 
maize feed for male rats. c Equivalence testing of 50% GM maize 
feeds versus the corresponding 50% non-GM control maize feed for 
female rats. d Equivalence testing of 50% maize feeds versus the cor-
responding 33% maize feeds and of 33% GM maize feeds versus the 
33% non-GM maize feed for female rats. In all subplots, for estimates 
on the left of zero, the first mentioned feed has a smaller mean than 
the last mentioned feed. Endpoints labelled with a yellow background 
have a larger residual variance compared to the historical studies 
(variance ratio > 150%). Fuchsia coloured symbols denote a signifi-
cant difference
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Fig. 4  (continued)










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1115Archives of Toxicology (2019) 93:1095–1139 
1 3
In female rats, ALT was significantly higher in the group 
fed the 50% NK603 + Roundup diet than in the group fed 
the 33% NK603 + Roundup diet, whereas it was signifi-
cantly lower in the group fed the 33% NK603 + Roundup 
diet than in the 33% control group. ALB was significantly 
lower in the group fed the 50% NK603 + Roundup diet than 
in the group fed the 33% NK603 + Roundup diet. CHOL 
was significantly lower in the 50% NK603 group than in 
the 33% NK603 group and the 33% NK603 + Roundup 
group; moreover, CHOL was significantly lower in the 
50% NK603 + Roundup group than in the 50% control 
group. TAG levels were significantly lower in the group 
fed the 50% NK603 + Roundup diet than in the group fed 
the 50% control diet and the 33% NK603 + Roundup diet. 
CREA was significantly lower in the group fed the 50% 
NK603 + Roundup diet than in the group fed the 33% 
NK603 + Roundup diet. The Ca level was significantly 
lower in the group fed the 50% NK603 + Roundup diet than 
Table 9  Clinical biochemistry parameters (mean ± SD) in the serum of male and female Wistar Han RCC rats in the 90-day feeding trial with 
GM maize NK603 at an inclusion rate of up to 50% in the diet
a Statistically significant difference to the 50% control value based on the 95% confidence interval
b Statistically significant difference to the 33% control value based on the 95% confidence interval
c Statistically significant difference to the 33% NK603 value based on the 95% confidence interval
d Statistically significant difference to the 33% NK603 + Roundup value based on the 95% confidence interval







 ALP (µkat/L) 1.39 ± 0.29 1.28 ± 0.19 1.47 ± 0.32 1.29 ± 0.18 1.19 ± 0.15 1.20 ± 0.21 1.35 ± 0.22 1.33 ± 0.30
 ALT (µkat/L) 0.53 ± 0.07 0.54 ± 0.10 0.66 ± 0.17 0.52 ± 0.08 0.53 ± 0.08 0.64 ± 0.34 0.55 ± 0.07 0.57 ± 0.10
 AST (µkat/L) 2.42 ± 0.45 2.37 ± 0.37 2.92 ± 1.01 2.28 ± 0.30 2.46 ± 0.54 2.67 ± 0.68 2.39 ± 0.24 2.57 ± 0.71
 ALB (g/L) 38.4 ± 1.58 37.5 ± 0.64 39.3 ± 2.95a 38.2 ± 1.48 38.3 ± 0.82 39.0 ± 3.75 38.3 ± 1.36 38.4 ± 0.67
 TP (g/L) 66.2 ± 2.26 64.2 ± 0.76b 65.5 ± 2.10 65.4 ± 1.26 65.4 ± 0.67 64.6 ± 1.71 65.7 ± 1.69 65.6 ± 1.01
 GLU 
(mmol/L)
5.74 ± 0.61 5.58 ± 0.90 5.45 ± 0.84 5.40 ± 0.33 5.22 ± 0.76 5.70 ± 0.48 5.29 ± 0.33 5.03 ± 0.69
 CHOL 
(mmol/L)
2.15 ± 0.24 2.13 ± 0.26 2.11 ± 0.17 2.08 ± 0.17 2.23 ± 0.14 2.25 ± 0.09 2.11 ± 0.22 2.26 ± 0.26
 TAG (mmol/L) 1.07 ± 0.24 1.13 ± 0.30 1.12 ± 0.17 1.27 ± 0.24 1.18 ± 0.17 1.18 ± 0.23 1.12 ± 0.22 1.20 ± 0.24
 CREA 
(mmol/L)
36.2 ± 5.35 33.4 ± 5.31 32.3 ± 3.34 34.4 ± 4.11 34.9 ± 6.61 32.2 ± 7.05 33.3 ± 7.31 33.3 ± 5.95
 UREA 
(mmol/L)
5.46 ± 0.97 4.96 ± 0.56 4.91 ± 0.90 4.84 ± 0.87b 4.69 ± 0.39 5.50 ± 0.79a 5.31 ± 0.57 4.86 ± 0.70
 Ca (mmol/L) 2.39 ± 0.04 2.39 ± 0.04 2.37 ± 0.04 2.40 ± 0.05 2.40 ± 0.04 2.39 ± 0.04 2.39 ± 0.04 2.39 ± 0.03
 Cl (mmol/L) 99 ± 1.95 100 ± 1.03 100 ± 1.90 100 ± 2.42 101 ± 2.19 100 ± 2.63 100 ± 2.31 99 ± 1.36
 K (mmol/L) 4.56 ± 0.27 4.44 ± 0.21 4.89 ± 0.88a 4.51 ± 0.37 4.66 ± 0.37 4.50 ± 0.24 4.43 ± 0.19 4.56 ± 0.21
 Na (mmol/L) 144 ± 2.43 144 ± 1.75 143 ± 1.67 143 ± 1.77 145 ± 1.70 143 ± 2.10 145 ± 2.40 143 ± 2.41
 P (mmol/L) 2.19 ± 0.41 2.00 ± 0.14 2.11 ± 0.26 2.22 ± 0.19 1.99 ± 0.23 2.02 ± 0.42 2.22 ± 0.21 2.04 ± 0.19
Female rats
ALP (µkat/L) 0.64 ± 0.08 0.66 ± 0.14 0.59 ± 0.11 0.72 ± 0.14 0.64 ± 0.13 0.63 ± 0.13 0.62 ± 0.16 0.68 ± 0.10
ALT (µkat/L) 0.50 ± 0.08 0.48 ± 0.06 0.48 ± 0.06 0.47 ± 0.06 0.49 ± 0.07 0.48 ± 0.04 0.43 ± 0.10b 0.50 ± 0.08d
AST (µkat/L) 2.40 ± 0.30 2.22 ± 0.45 2.36 ± 0.57 2.21 ± 0.38 2.44 ± 0.60 2.29 ± 0.58 2.48 ± 0.67 2.29 ± 0.43
ALB (g/L) 44.4 ± 2.39 44.0 ± 2.00 42.7 ± 1.48 46.1 ± 3.07 44.7 ± 1.87 43.1 ± 1.59 44.7 ± 2.08 42.7 ± 2.54d
TP (g/L) 70.4 ± 3.06 69.2 ± 2.44 68.6 ± 1.98 72.1 ± 4.36 70.4 ± 2.27 68.4 ± 2.05 70.1 ± 3.21 68.6 ± 4.49
GLU (mmol/L) 4.87 ± 0.56 5.24 ± 0.90 4.95 ± 0.76 5.16 ± 0.50 5.01 ± 0.77 5.25 ± 1.03 5.05 ± 0.72 5.36 ± 0.88
CHOL 
(mmol/L)
1.83 ± 0.34 1.63 ± 0.23 1.57 ± 0.41 1.95 ± 0.35 1.65 ± 0.44c 1.54 ± 0.30 1.68 ± 0.29 1.34 ± 0.19a,d
TAG (mmol/L) 0.56 ± 0.12 0.52 ± 0.09 0.51 ± 0.13 0.56 ± 0.07 0.48 ± 0.06 0.48 ± 0.09 0.54 ± 0.15 0.43 ± 0.11a,d
CREA 
(mmol/L)
35.4 ± 3.91 36.5 ± 3.11 38.5 ± 6.08 35.3 ± 3.06 37.7 ± 4.34 37.6 ± 3.50 37.6 ± 3.58 34.0 ± 4.00d
UREA 
(mmol/L)
5.48 ± 0.33 5.93 ± 0.59 6.47 ± 0.80 5.96 ± 0.76 5.87 ± 0.64 6.36 ± 0.54 5.90 ± 0.55 5.85 ± 0.81
Ca (mmol/L) 2.46 ± 0.05 2.46 ± 0.03 2.43 ± 0.05 2.49 ± 0.06 2.46 ± 0.04 2.43 ± 0.04 2.41 ± 0.03b 2.42 ± 0.03a
Cl (mmol/L) 101 ± 1.41 103 ± 1.87b 102 ± 1.83 102 ± 2.20 102 ± 0.99 102 ± 1.45 101 ± 1.33 102 ± 1.35
K (mmol/L) 4.09 ± 0.20 4.19 ± 0.23 4.31 ± 0.46 4.24 ± 0.48 4.09 ± 0.34 4.17 ± 0.46 4.32 ± 0.67 4.15 ± 0.46
Na (mmol/L) 143 ± 2.11 144 ± 1.28 143 ± 1.69 144 ± 1.49 144 ± 1.39 143 ± 0.90 144 ± 1.62 143 ± 1.51
P (mmol/L) 1.62 ± 0.36 1.65 ± 0.40 1.63 ± 0.32 1.84 ± 0.30 1.64 ± 0.17 1.66 ± 0.30 1.87 ± 0.38 1.71 ± 0.36
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in the group fed the 50% control diet and in the group fed the 
33% NK603 + Roundup diet when compared to the group 
fed the 33% control diet. Apart from these 16 significances, 
the other 254 comparisons involving the 15 clinical bio-
chemical parameters in male and female rats over nine types 
of comparison (see headers in Fig. 4) showed no significant 
differences. The equivalence tests showed “equivalence” 
for 266 comparisons involving the 15 biochemical param-
eters, whereas the conclusion was “equivalence more likely 
than not” in four cases (Fig. 4a–d). One of the ELSD con-
fidence limits was outside the interval [− 1, + 1] for CHOL 
in female rats fed the 50% NK603 + Roundup diet relative 
to the 50% control diet and the 33% NK603 + Roundup diet, 
for CHOL in female rats fed the 50% NK603 diet relative 
to the 33% NK603 diet and for P levels in female rats fed 
the 33% NK603 + Roundup diet relative to the 33% control 
diet (Fig. 4c, d).
The urinalysis data are summarized in the statistical 
report by Goedhart and van der Voet (2018f). The urine 
pH was significantly lower in male rats fed the 50% 
NK603 + Roundup diet than in the group fed the 33% 
NK603 + Roundup diet. In female rats, the urine volume 
and pH were significantly lower in the group fed the 50% 
NK603 diet than in the group fed the 33% NK603 diet, 
while the urine volume/body weight was significantly 
higher in the group fed the 33% NK603 diet than in the 
group fed the 33% control diet and the urine osmolarity 
was significantly lower in the group fed the 33% NK603 
diet than in the group fed the 33% control diet. Apart from 
these 5 significances, the other 103 comparisons regard-
ing the 6 urinalysis parameters showed no significant 
differences.
The relative organ weights in male and female rats are 
shown in Table 10 and Fig. 4. In male rats fed the 50% 
NK603 diet, the relative brain and testis weights were 
significantly higher than those in the 50% control group 
and the relative heart weight and thymus weight were sig-
nificantly higher than that in the 33% NK603 group. The 
relative heart weight in the 33% NK603 group was sig-
nificantly lower than in the 33% control group. In female 
rats fed the 50% NK603 + Roundup diet, the relative kid-
ney and ovary weights were significantly higher than those 
in the 50% control group and the relative heart and ovary 
weights were significantly higher than those in the 33% 
NK603 + Roundup group. The relative thymus weight in 
the 11% NK603 + Roundup group was significantly lower 
than in the 50% control group. Apart from these 10 sig-
nificances, the other 152 comparisons involving the 10 rela-
tive organ weights in male and female rats over 9 types of 
comparison (see headers in Fig. 4) showed no significant 
Table 10  Relative organ weights in male and female Wistar Han RCC rats in the 90-day feeding trial with GM maize NK603 at an inclusion rate 
of up to 50% in the diet
a Statistically significant difference to the 50% control value based on the 95% confidence interval
b Statistically significant difference to the corresponding 33% (i.e. 33% NK603 or 33% NK603 + Roundup) value based on the 95% confidence 
interval
Organ Relative organ weights (organ weight/body weight × 100)







 Adrenal glands 0.014 ± 0.001 0.014 ± 0.002 0.014 ± 0.002 0.013 ± 0.002 0.014 ± 0.002 0.014 ± 0.002 0.013 ± 0.002 0.014 ± 0.002
 Brain 0.51 ± 0.02 0.49 ± 0.02 0.51 ± 0.03 0.51 ± 0.02 0.52 ± 0.03a 0.50 ± 0.02 0.51 ± 0.02 0.50 ± 0.04
 Epididymides 0.29 ± 0.01 0.28 ± 0.03 0.28 ± 0.03 0.28 ± 0.03 0.30 ± 0.02 0.30 ± 0.01 0.29 ± 0.01 0.29 ± 0.02
 Heart 0.26 ± 0.01 0.25 ± 0.01 0.25 ± 0.02 0.24 ± 0.01 0.26 ± 0.01b 0.26 ± 0.02 0.26 ± 0.02 0.26 ± 0.01
 Kidneys 0.54 ± 0.03 0.54 ± 0.03 0.56 ± 0.03 0.53 ± 0.04 0.55 ± 0.04 0.56 ± 0.02 0.58 ± 0.04 0.55 ± 0.02
 Liver 2.35 ± 0.10 2.27 ± 0.10 2.22 ± 0.10 2.29 ± 0.07 2.34 ± 0.10 2.34 ± 0.09 2.29 ± 0.08 2.30 ± 0.09
 Spleen 0.17 ± 0.02 0.16 ± 0.01 0.16 ± 0.01 0.17 ± 0.02 0.17 ± 0.02 0.17 ± 0.02 0.17 ± 0.02 0.17 ± 0.02
 Testes 0.86 ± 0.05 0.82 ± 0.06 0.83 ± 0.05 0.85 ± 0.08 0.88 ± 0.05a 0.86 ± 0.04 0.83 ± 0.07 0.86 ± 0.05
 Thymus 0.10 ± 0.01 0.10 ± 0.01 0.09 ± 0.01 0.09 ± 0.01 0.10 ± 0.01 0.10 ± 0.02 0.10 ± 0.01 0.09 ± 0.01
Female rats
 Adrenal glands 0.031 ± 0.003 0.030 ± 0.001 0.029 ± 0.002 0.030 ± 0.004 0.032 ± 0.003 0.031 ± 0.002 0.030 ± 0.002 0.031 ± 0.003
 Brain 0.81 ± 0.02 0.86 ± 0.05 0.85 ± 0.07 0.83 ± 0.04 0.86 ± 0.07 0.82 ± 0.06 0.83 ± 0.06 0.87 ± 0.08
 Heart 0.31 ± 0.03 0.30 ± 0.01 0.30 ± 0.01 0.30 ± 0.02 0.31 ± 0.02 0.31 ± 0.02 0.30 ± 0.01 0.32 ± 0.03b
 Kidneys 0.58 ± 0.02 0.58 ± 0.04 0.59 ± 0.05 0.58 ± 0.05 0.60 ± 0.03 0.60 ± 0.05 0.59 ± 0.04 0.63 ± 0.04a
 Liver 2.44 ± 0.10 2.40 ± 0.07 2.41 ± 0.23 2.51 ± 0.19 2.46 ± 0.14 2.35 ± 0.13 2.35 ± 0.07 2.38 ± 0.11
 Ovaries 0.040 ± 0.003 0.040 ± 0.005 0.039 ± 0.005 0.037 ± 0.006 0.040 ± 0.006 0.040 ± 0.003 0.039 ± 0.007 0.046 ± 0.009a,b
 Spleen 0.21 ± 0.02 0.21 ± 0.01 0.22 ± 0.03 0.22 ± 0.02 0.23 ± 0.03 0.22 ± 0.02 0.21 ± 0.01 0.23 ± 0.03
 Thymus 0.13 ± 0.02 0.13 ± 0.02 0.13 ± 0.02 0.13 ± 0.02 0.13 ± 0.02 0.12 ± 0.01 0.13 ± 0.01 0.12 ± 0.02
 Uterus 0.25 ± 0.04 0.26 ± 0.07 0.30 ± 0.08 0.27 ± 0.07 0.27 ± 0.07 0.25 ± 0.06 0.26 ± 0.06 0.26 ± 0.06
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differences. The equivalence tests showed “equivalence” for 
all but one of the 162 comparisons, and “equivalence more 
likely than not” for relative kidney weight in female rats fed 
the 50% NK603 + Roundup diet relative to the 50% control 
diet (Fig. 4c).
The summary tables with all necropsy findings observed 
in male and female rats are listed in the Supplementary Elec-
tronic Material’s Tables 8 and 9, respectively, those with 
all histopathological findings observed in male and female 
rats are listed in the Supplementary Electronic Material’s 
Tables 10 and 11, respectively. There were no treatment-
related necropsy and histopathological findings following 
the feeding of NK603 or NK603 + Roundup to rats up to 
50% inclusion rate for 90 days.
Combined chronic toxicity/carcinogenicity feeding 
trial with the GM maize NK603 at an inclusion rate 
of 11 and 33% in the diets
The study design is shown in Table  11. The male and 
female rat mortality rates in the five experimental groups 
are shown in Table 12. The mortality rate of the male rats 
fed the 33% NK603 + Roundup diet was significantly higher 
than that of the corresponding control group (p = 0.03 in 
a one-sided test). In contrast, the female rats fed the 33% 
NK603 + Roundup diet showed a lower, though not signifi-
cantly lower mortality rate than the corresponding control 
group (p = 0.07 if the test would have been performed for 
decreased rather than increased mortality).
The body weight of the male and female rats surviving 
until the end of the 2-year feeding period is shown in Fig. 5. 
The male rats fed the NK603 + Roundup diet at an inclusion 
rate of 33% showed a significantly higher body weight when 
compared to the corresponding control group in the second 
half of the experimental period, while the body weight of 
the female rats was similar in all five experimental groups 
(Fig. 5). The mean feed consumption of male and female 
rats surviving until the end of the 2-year feeding period was 
similar to the respective control groups (Fig. 6). The equiv-
alence tests were only performed for the data after 3 and 
6 months, since there was only one set of control data from a 
1-year feeding trial performed in the course of the preceding 
GRACE project, but no historical control data from a 2-year 
feeding trial at the animal housing facility. The equivalence 
tests showed “equivalence” for body weight and mean feed 
consumption at t = 3 and t = 6 months in male and female 
rats, i.e. all ELSD intervals were fully inside the interval 
[− 1, + 1]. Figures for all parameter groups are shown in 
Goedhart and van der Voet (2018a, i).
The data on the haematological parameters measured in 
the blood samples of the male rats are shown in Table 13. 
At t = 3 months, WBC were significantly higher in the 
group fed the 33% NK603 diet than in the control group. At 
t = 6 months, WBC and LYMA were significantly higher in 
the groups fed the 33% NK603 and 11% NK603 + Roundup 
diets than in the control group, while the percentage mono-
cytes was significantly lower in the group fed the 11% 
NK603 diet than in the control group. At t = 12 months, 
Table 11  Study design of the 
combined chronic toxicity/
carcinogenicity feeding trial 
with the GM maize NK603 at 
an inclusion rate of 11 and 33% 
in the diet




NK603 NK603 + Roundup Males Females Males Females
1 33 0 0 20 20 50 50
2 22 11 0 20 20 50 50
3 0 33 0 20 20 50 50
4 22 0 11 20 20 50 50
5 0 0 33 20 20 50 50
Sentinels 10 10
Total 100 100 260 260
Table 12  Male and female rat mortality rate in the combined chronic toxicity/carcinogenicity feeding trial with the GM maize NK603 at an 
inclusion rate of 11 and 33% in the diet
Shown is the number of male and female rats that died or had to be sacrificed prematurely/total number of rats per group and the corresponding 
percentage in parentheses
33% Control 11% NK603 33% NK603 11% NK603 + Roundup 33% NK603 + Roundup
Male rats 18/50 (36%) 14/50 (28%) 17/50 (34%) 18/50 (36%) 27/50 (54%)
Female rats 24/50 (48%) 26/50 (52%) 20/50 (40%) 19/50 (38%) 17/50 (34%)
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HCT was significantly higher and MCHC was signifi-
cantly lower in the group fed the 11% NK603 + Roundup 
diet than in the control group, while PLT was significantly 
higher in the groups fed the 33% NK603 and the 33% 
NK603 + Roundup diets than in the control group. The 
data on the haematological parameters measured in the 
blood samples of the female rats are shown in Table 14. At 
t = 6 months, PLT was significantly higher in the group fed 
the 11% NK603 + Roundup diet than in the control group, 
whereas the percentage monocytes was significantly lower 
in the group fed the 33% NK603 + Roundup diet than in 
the control group. At t = 12 months, MCH was significantly 
lower in the groups fed the 11% NK603 + Roundup and the 
33% NK603 + Roundup diets and MCHC was significantly 
lower in the group fed the 11% NK603 + Roundup diet than 
in the control group. Moreover, the percentage lympho-
cytes was significantly lower and the percentage neutrophils 
significantly higher in the group fed the 11% NK603 diet 
than in the control group. At t = 24 months, the percent-
age eosinophils was significantly higher in the group fed the 
33% NK603 diet than in the control group. Apart from these 
21 cases of significance, the other 427 comparisons involv-
ing the 14 haematological parameters in male and female 
rats across 4 points in time and 4 NK603 groups showed no 
significant differences between the NK603 groups and the 
control group.
The differential white blood count data in the present data 
were much more variable than the historical reference data. 
This indicates that the analytical methods used in the current 
and historical study were not comparable, and therefore, the 
historical data were not considered suitable to be used for 
equivalence tests (see details in Goedhart and van der Voet 
2018i). The equivalence tests for the remaining 9 haema-
tological parameters showed “equivalence” in the case of 
131 comparisons, “equivalence more likely than not” for 12 
comparisons, and “non-equivalence more likely than not” 
for one of the 144 comparisons with the control group. The 
latter case, in which the ELSD point estimate was outside 
the equivalence area between − 1 and + 1, was the percent-
age monocytes in female rats fed the 33% NK603 + Roundup 
diet at t = 6 months. Furthermore, one or both ELSD con-
fidence limits were outside the interval [− 1, + 1] for MCV 
Fig. 5  Mean body weight of all male and female rats surviving until 
the points in time plotted in the combined chronic toxicity/carcino-
genicity feeding trial with GM maize NK603 at an inclusion rate of 
11 and 33% in the diet
Fig. 6  Mean feed consumption of all male and female rats surviving 
until the points in time plotted in the combined chronic toxicity/carci-
nogenicity feeding trial with GM maize NK603 at an inclusion rate of 
11 and 33% in the diet
1119Archives of Toxicology (2019) 93:1095–1139 
1 3
Table 13  Haematology parameters (mean ± SD) in the serum of male Wistar Han RCC rats in the combined chronic toxicity/carcinogenicity 
feeding trial with GM maize NK603 at an inclusion rate of 11 and 33% in the diet
Parameter Time 
(months)
33% Control 11% NK603 33% NK603 11% NK603 + Roundup 33% 
NK603 + Roundup
Male rats
 WBC  (109/L) 3 10.1 ± 1.37 10.2 ± 2.08 11.5 ± 1.44a 10.9 ± 2.39 11.2 ± 2.60
6 9.10 ± 1.63 8.90 ± 1.95 10.8 ± 1.88a 10.5 ± 1.84a 9.60 ± 1.94
12 7.66 ± 1.59 7.20 ± 1.50 8.57 ± 1.59 7.81 ± 1.18 8.15 ± 1.08
24 9.40 ± 3.57 9.90 ± 4.82 8.60 ± 2.97 9.80 ± 3.39 11.2 ± 5.70
 RBC  (1012/L) 3 8.64 ± 0.32 8.58 ± 0.28 8.61 ± 0.25 8.67 ± 0.27 8.60 ± 0.29
6 8.46 ± 0.33 8.49 ± 0.31 8.47 ± 0.28 8.45 ± 0.28 8.52 ± 0.26
12 8.48 ± 0.27 8.50 ± 0.35 8.45 ± 0.38 8.65 ± 0.35 8.58 ± 0.44
24 7.89 ± 0.42 7.76 ± 0.63 7.96 ± 0.50 7.86 ± 0.69 7.88 ± 0.61
 HGB (g/dL) 3 16.2 ± 0.50 16.1 ± 0.42 16.2 ± 0.40 16.0 ± 0.43 16.2 ± 0.45
6 15.6 ± 0.51 15.7 ± 0.57 15.8 ± 0.53 15.6 ± 0.48 15.9 ± 0.43
12 15.8 ± 0.26 15.9 ± 0.50 15.9 ± 0.49 16.0 ± 0.45 16.0 ± 0.61
24 15.4 ± 0.90 15.0 ± 1.33 15.6 ± 0.90 15.3 ± 1.27 15.5 ± 1.16
 HCT (%) 3 46.5 ± 1.66 46.1 ± 1.23 46.5 ± 1.36 46.7 ± 1.31 46.6 ± 1.52
6 45.8 ± 1.54 46.0 ± 1.45 46.2 ± 1.67 45.6 ± 1.47 46.4 ± 1.25
12 46.1 ± 1.29 46.3 ± 1.53 46.5 ± 2.07 47.2 ± 1.35a 46.8 ± 2.15
24 44.1 ± 2.50 44.2 ± 2.70 44.5 ± 1.95 43.9 ± 3.27 44.2 ± 3.32
 MCV (fL) 3 53.9 ± 1.44 53.8 ± 1.45 54.0 ± 1.20 53.8 ± 1.20 54.2 ± 1.19
6 54.0 ± 0.78 54.3 ± 1.47 54.6 ± 1.48 54.0 ± 1.15 54.5 ± 0.98
12 54.4 ± 1.55 54.6 ± 1.56 55.0 ± 1.56 54.6 ± 1.52 54.8 ± 1.20
24 55.6 ± 2.10 56.5 ± 1.57 56.6 ± 2.09 56.0 ± 1.59 56.2 ± 1.86
 MCH (pg) 3 18.7 ± 0.65 18.7 ± 0.69 18.9 ± 0.55 18.5 ± 0.49 18.8 ± 0.66
6 18.5 ± 0.61 18.6 ± 0.82 18.7 ± 0.64 18.5 ± 0.55 18.7 ± 0.52
12 18.7 ± 0.63 18.8 ± 0.73 18.8 ± 0.74 18.5 ± 0.76 18.7 ± 0.65
24 19.5 ± 0.76 19.5 ± 0.71 19.6 ± 0.90 19.5 ± 0.86 19.7 ± 0.96
 MCHC (g/dL) 3 34.8 ± 0.54 34.8 ± 0.56 34.9 ± 0.52 34.4 ± 0.50a 34.7 ± 0.76
6 34.1 ± 0.62 34.2 ± 0.79 34.3 ± 0.61 34.3 ± 0.71 34.3 ± 0.56
12 34.3 ± 0.57 34.3 ± 0.76 34.2 ± 0.90 33.9 ± 0.64a 34.2 ± 0.72
24 34.9 ± 0.77 34.6 ± 0.67 34.7 ± 0.86 34.8 ± 0.76 35.1 ± 0.86
 PLT  (109/L) 3 824 ± 123 847 ± 106 870 ± 124 860 ± 67 888 ± 107
6 829 ± 44 812 ± 105 872 ± 88 864 ± 67 865 ± 112
12 814 ± 66 807 ± 61 879 ± 84a 834 ± 81 883 ± 84a
24 827 ± 118 850 ± 87 881 ± 187 867 ± 193 859 ± 146
 LYMR (%) 3 73.3 ± 5.21 72.5 ± 5.90 72.2 ± 6.84 73.2 ± 4.60 73.7 ± 3.74
6 71.4 ± 4.48 69.9 ± 4.90 70.5 ± 6.07 71.5 ± 6.06 72.3 ± 3.99
12 66.9 ± 8.77 66.8 ± 5.02 69.5 ± 8.88 67.5 ± 8.09 66.5 ± 7.83
24 58.4 ± 13.5 61.5 ± 14.1 61.0 ± 12.1 61.1 ± 11.8 56.9 ± 13.9
 LYMA  (103/µL) 3 7.39 ± 1.11 7.52 ± 1.85 8.26 ± 1.34 7.98 ± 1.84 8.24 ± 2.14
6 6.52 ± 1.17 6.19 ± 1.34 7.53 ± 1.33a 7.47 ± 1.37a 6.99 ± 1.67
12 5.13 ± 1.25 4.98 ± 1.18 5.90 ± 1.23 5.25 ± 0.85 5.31 ± 1.10
24 4.68 ± 1.84 5.14 ± 1.59 5.04 ± 2.03 5.31 ± 1.50 4.75 ± 1.54
 Lymphocytes (%) 3 71.3 ± 4.1 70.8 ± 5.7 71.4 ± 5.2 70.7 ± 5.9 70.6 ± 8.5
6 69.7 ± 5.2 70.8 ± 4.6 68.7 ± 5.3 70.0 ± 6.5 71.3 ± 4.3
12 61.5 ± 6.0 60.5 ± 5.3 62.4 ± 6.0 60.2 ± 9.6 62.0 ± 5.5
24 47.1 ± 14.7 45.1 ± 12.0 49.6 ± 7.8 48.8 ± 12.5 46.2 ± 15.0
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a Statistically significant difference to the 33% control value based on the 95% confidence interval
Table 13  (continued)
Parameter Time 
(months)
33% Control 11% NK603 33% NK603 11% NK603 + Roundup 33% 
NK603 + Roundup
 Neutrophils (%) 3 24.7 ± 4.2 25.1 ± 5.7 25.9 ± 8.5 25.0 ± 6.0 25.4 ± 8.4
6 27.0 ± 4.9 26.1 ± 4.0 27.4 ± 5.3 26.3 ± 5.8 25.1 ± 4.0
12 36.4 ± 5.8 37.1 ± 5.5 35.0 ± 6.0 37.3 ± 9.0 35.7 ± 5.6
24 48.2 ± 13.6 49.7 ± 11.5 45.6 ± 8.2 46.6 ± 12.6 50.0 ± 14.4
 Monocytes (%) 3 1.9 ± 0.5 2.2 ± 0.8 2.0 ± 0.7 2.1 ± 0.8 2.0 ± 0.6
6 1.2 ± 0.5 0.9 ± 0.4a 1.1 ± 0.5 1.0 ± 0.5 1.0 ± 0.4
12 0.5 ± 0.3 0.6 ± 0.4 0.7 ± 0.4 0.7 ± 0.4 0.7 ± 0.5
24 3.5 ± 2.8 3.7 ± 2.1 3.2 ± 1.7 3.2 ± 1.6 2.8 ± 2.3
 Eosinophils (%) 3 2.1 ± 1.0 1.8 ± 1.1 2.2 ± 0.9 2.2 ± 1.0 2.0 ± 1.0
6 2.2 ± 1.2 2.2 ± 1.3 2.8 ± 1.2 2.6 ± 1.7 2.5 ± 0.8
12 1.6 ± 1.1 1.8 ± 1.1 1.9 ± 0.7 1.8 ± 1.4 1.6 ± 0.8
24 1.2 ± 0.9 1.4 ± 1.0 1.6 ± 0.8 1.4 ± 1.2 1.0 ± 1.0
Table 14  Haematology parameters (mean ± SD) in the serum of female Wistar Han RCC rats in the combined chronic toxicity/carcinogenicity 
feeding trial with GM maize NK603 at an inclusion rate of 11 and 33% in the diet
Parameter Time 
(months)
33% Control 11% NK603 33% NK603 11% NK603 + Roundup 33% NK603 + Roundup
Female rats
 WBC  (109/L) 3 7.54 ± 1.63 7.84 ± 1.24 7.80 ± 2.24 7.28 ± 1.12 8.02 ± 1.36
6 5.86 ± 1.35 5.97 ± 0.94 6.12 ± 1.71 5.59 ± 1.27 6.05 ± 1.30
12 5.57 ± 1.34 5.94 ± 1.53 5.13 ± 0.96 5.45 ± 1.19 5.88 ± 1.28
24 7.80 ± 0.59 7.80 ± 2.60 6.90 ± 3.40 10.4 ± 10.2 8.10 ± 3.60
 RBC  (1012/L) 3 7.62 ± 0.33 7.62 ± 0.31 7.73 ± 0.35 7.70 ± 0.29 7.73 ± 0.37
6 7.66 ± 0.30 7.64 ± 0.25 7.71 ± 0.30 7.68 ± 0.19 7.72 ± 0.27
12 7.37 ± 0.36 7.37 ± 0.31 7.44 ± 0.35 7.55 ± 0.29 7.54 ± 0.25
24 7.19 ± 0.57 7.15 ± 0.45 7.19 ± 0.68 7.08 ± 0.77 7.26 ± 0.50
 HGB (g/dL) 3 15.5 ± 0.59 15.4 ± 0.52 15.6 ± 0.57 15.4 ± 0.52 15.4 ± 0.51
6 15.6 ± 0.44 15.4 ± 0.52 15.5 ± 0.29 15.4 ± 0.29 15.5 ± 0.41
12 15.4 ± 0.53 15.4 ± 0.52 15.5 ± 0.51 15.6 ± 0.48 15.5 ± 0.54
24 15.2 ± 0.56 14.9 ± 0.84 14.8 ± 0.87 15.0 ± 1.09 15.1 ± 0.67
 HCT (%) 3 44.4 ± 1.31 44.2 ± 1.35 44.9 ± 1.03 44.1 ± 0.88 44.8 ± 1.74
6 44.1 ± 1.55 44.0 ± 1.45 44.3 ± 1.03 44.1 ± 0.88 44.2 ± 1.41
12 43.2 ± 2.00 43.3 ± 1.90 43.8 ± 1.63 44.1 ± 1.56 43.9 ± 1.38
24 42.6 ± 2.62 42.0 ± 2.82 41.3 ± 2.84 42.2 ± 2.81 42.1 ± 1.75
 MCV (fL) 3 58.4 ± 2.27 58.4 ± 1.50 58.0 ± 1.90 58.0 ± 1.52 58.0 ± 1.73
6 57.7 ± 0.96 57.6 ± 0.90 57.4 ± 1.14 57.4 ± 0.80 57.2 ± 0.99
12 58.7 ± 0.86 58.9 ± 1.16 58.7 ± 1.25 58.4 ± 0.98 58.2 ± 1.19
24 58.2 ± 1.91 58.8 ± 2.09 57.6 ± 2.30 58.5 ± 1.77 57.7 ± 1.66
 MCH (pg) 3 20.4 ± 1.15 20.4 ± 1.10 20.2 ± 0.89 20.0 ± 0.86 20.0 ± 0.76
6 20.4 ± 0.52 20.2 ± 0.53 20.1 ± 0.69 20.1 ± 0.49 20.1 ± 0.64
12 21.0 ± 0.55 21.0 ± 0.60 20.8 ± 0.75 20.6 ± 0.42a 20.6 ± 0.50a
24 20.9 ± 0.81 20.9 ± 0.87 20.8 ± 1.24 20.8 ± 1.19 20.8 ± 0.99
 MCHC (g/dL) 3 34.9 ± 0.94 34.9 ± 0.94 34.8 ± 0.99 34.6 ± 1.14 34.5 ± 0.95
6 35.3 ± 0.76 35.1 ± 0.76 34.9 ± 0.40 34.9 ± 0.59 35.2 ± 0.87
12 35.8 ± 0.72 35.6 ± 0.86 35.3 ± 0.73 35.2 ± 0.63a 35.4 ± 0.82
24 35.8 ± 0.59 35.6 ± 0.90 35.5 ± 1.02 35.5 ± 0.93 35.8 ± 0.72
1121Archives of Toxicology (2019) 93:1095–1139 
1 3
in male rats fed any NK603 diet at t = 3 months and male 
rats fed the 33% NK603 or the 33% NK603 + Roundup 
diet at t = 6 months, for MCH in male rats fed any NK603 
diet at t = 6 months, as well as for MCHC in female rats 
fed the 33% NK603 + Roundup diet at t = 3 months or the 
11% NK603 + Roundup diet or the 33% NK603 diet at 
t = 6 months.
The data on the clinical biochemical parameters in male 
rats are shown in Table 15. The TAG levels were signifi-
cantly higher in the groups fed the 11% NK603 + Roundup 
diet than in the control group at t = 6 and 12 months, while 
UREA was significantly higher in the group fed the 11% 
NK603 diet than in the control group at t = 24 months. Cl was 
significantly lower in the groups fed the 33% NK603, 11% 
NK603 + Roundup and 33% NK603 + Roundup diets than in 
the control group at t = 12 months, whereas K was signifi-
cantly higher in the group fed the 11% NK603 + Roundup 
diet than in the control group at t = 24 months and P was 
significantly lower in the group fed the 11% NK603 diet 
than in the control group at t = 12 months. The data on the 
clinical biochemical parameters in female rats are shown 
in Table 16. ALT was significantly lower in the group fed 
the 11% NK603 + Roundup diet than in the control group 
after 12 months and AST was significantly higher in the 
group fed the 33% NK603 + Roundup diet than in the control 
group at t = 6 months. TAG was significantly lower in the 
group fed the 11% NK603 + Roundup diet than in the con-
trol group at t = 6 months. CREA was significantly higher 
in the group fed the 11% NK603 diet than in the control 
group at t = 12 months and was significantly higher in the 
groups fed the 33% NK603, 11% NK603 + Roundup and 
33% NK603 + Roundup diets than in the control group at 
t = 24 months. UREA was significantly higher in all four 
groups fed the NK603 containing diets than in the control 
group at t = 12 months. Cl was significantly higher in the 
group fed the 11% NK603 + Roundup diet than in the control 
a Statistically significant difference to the 33% control value based on the 95% confidence interval
Table 14  (continued)
Parameter Time 
(months)
33% Control 11% NK603 33% NK603 11% NK603 + Roundup 33% NK603 + Roundup
 PLT  (109/L) 3 828 ± 71 799 ± 81 787 ± 87 813 ± 84 846 ± 79
6 843 ± 82 794 ± 63 812 ± 69 786 ± 92a 819 ± 117
12 755 ± 75 792 ± 103 751 ± 74 764 ± 79 784 ± 97
24 784 ± 102 763 ± 165 837 ± 168 842 ± 199 889 ± 190
 LYMR (%) 3 73.7 ± 5.05 71.3 ± 7.26 72.7 ± 6.30 72.5 ± 8.03 74.1 ± 6.25
6 72.4 ± 3.94 71.2 ± 4.03 71.6 ± 5.22 72.2 ± 3.88 71.1 ± 5.25
12 69.9 ± 7.41 70.0 ± 5.44 71.4 ± 7.50 70.0 ± 6.10 70.6 ± 3.68
24 56.8 ± 9.10 55.2 ± 10.3 56.5 ± 9.40 57.5 ± 10.6 56.8 ± 9.80
 LYMA  (103/µL) 3 5.56 ± 1.22 5.69 ± 1.15 5.57 ± 1.41 5.22 ± 0.83 6.02 ± 1.38
6 4.21 ± 0.85 4.26 ± 0.75 4.35 ± 1.21 4.03 ± 0.94 4.28 ± 1.04
12 3.86 ± 0.97 3.92 ± 0.63 3.57 ± 0.60 3.78 ± 0.67 4.04 ± 0.80
24 3.47 ± 1.29 4.11 ± 1.58 3.23 ± 0.89 3.44 ± 0.86 3.72 ± 1.36
 Lymphocytes (%) 3 72.9 ± 7.5 71.9 ± 7.2 73.8 ± 6.7 71.2 ± 6.5 73.2 ± 7.0
6 67.7 ± 4.3 67.5 ± 4.3 67.4 ± 3.9 67.5 ± 3.5 69.3 ± 4.5
12 68.4 ± 7.4 62.8 ± 6.4a 66.5 ± 9.0 66.2 ± 6.7 66.7 ± 6.6
24 49.6 ± 14.3 46.7 ± 11.6 52.9 ± 8.1 47.3 ± 13.5 50.0 ± 13.2
 Neutrophils (%) 3 23.2 ± 6.4 24.4 ± 7.1 23.2 ± 6.6 24.9 ± 6.0 22.6 ± 6.4
6 29.0 ± 4.3 29.5 ± 4.1 29.6 ± 4.1 29.3 ± 3.8 27.9 ± 4.3
12 29.0 ± 7.3 34.3 ± 6.5a 30.7 ± 9.1 31.3 ± 6.9 30.1 ± 6.1
24 46.8 ± 13.9 49.8 ± 10.9 42.9 ± 8.5 48.8 ± 11.7 46.2 ± 13.4
 Monocytes (%) 3 1.9 ± 0.7 1.7 ± 0.7 1.7 ± 0.6 2.0 ± 0.9 2.0 ± 0.7
6 1.1 ± 0.6 0.9 ± 0.6 1.0 ± 0.6 0.9 ± 0.4 0.7 ± 0.4a
12 0.7 ± 0.9 0.8 ± 0.6 0.9 ± 0.7 0.8 ± 0.9 1.0 ± 0.9
24 2.3 ± 2.2 2.2 ± 1.4 2.4 ± 1.4 2.7 ± 2.5 2.4 ± 1.6
 Eosinophils (%) 3 2.1 ± 1.2 2.0 ± 1.2 1.3 ± 0.8 1.9 ± 0.8 2.2 ± 1.1
6 2.2 ± 0.8 2.2 ± 0.9 2.0 ± 1.0 2.3 ± 0.8 2.1 ± 1.2
12 1.9 ± 0.7 2.2 ± 1.2 1.9 ± 1.0 1.6 ± 0.6 2.2 ± 0.7
24 1.2 ± 0.7 1.4 ± 0.9 1.8 ± 1.1a 1.2 ± 0.7 1.4 ± 0.8
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Table 15  Clinical biochemistry parameters (mean ± SD) in the serum of male Wistar Han RCC rats in the combined chronic toxicity/carcino-
genicity feeding trial with GM maize NK603 at an inclusion rate of 11 and 33% in the diet
Parameter Time 
(months)
33% Control 11% NK603 33% NK603 11% NK603 + Roundup 33% 
NK603 + Roundup
ALP (µkat/L) 3 1.51 ± 0.33 1.54 ± 0.37 1.47 ± 0.26 1.47 ± 0.26 1.56 ± 0.41
6 1.39 ± 0.30 1.44 ± 0.36 1.34 ± 0.30 1.34 ± 0.30 1.37 ± 0.34
12 1.23 ± 0.22 1.33 ± 0.26 1.26 ± 0.21 1.26 ± 0.21 1.26 ± 0.22
24 1.09 ± 0.44 1.18 ± 0.56 0.95 ± 0.35 0.95 ± 0.35 0.84 ± 0.23
ALT (µkat/L) 3 0.66 ± 0.10 0.68 ± 0.16 0.64 ± 0.11 0.64 ± 0.10 0.64 ± 0.10
6 0.68 ± 0.09 0.70 ± 0.16 0.70 ± 0.15 0.68 ± 0.12 0.69 ± 0.10
12 0.66 ± 0.11 0.68 ± 0.19 0.64 ± 0.11 0.72 ± 0.18 0.69 ± 0.14
24 0.83 ± 0.17 0.90 ± 0.30 0.88 ± 0.26 0.88 ± 0.24 0.90 ± 0.27
AST (µkat/L) 3 2.27 ± 0.47 2.25 ± 0.34 2.18 ± 0.30 2.08 ± 0.48 2.12 ± 0.28
6 2.09 ± 0.41 2.15 ± 0.42 2.25 ± 0.42 2.15 ± 0.32 2.11 ± 0.31
12 2.30 ± 0.38 2.39 ± 0.52 2.29 ± 0.33 2.28 ± 0.54 2.32 ± 0.58
24 2.60 ± 0.66 3.05 ± 0.94 2.73 ± 0.66 2.85 ± 0.95 2.80 ± 0.82
ALB (g/L) 3 39.7 ± 1.92 39.2 ± 2.27 39.4 ± 1.86 38.8 ± 1.44 39.9 ± 2.78
6 35.0 ± 1.24 35.0 ± 1.32 35.3 ± 1.35 35.2 ± 1.32 35.2 ± 1.35
12 37.7 ± 1.22 37.4 ± 1.05 38.0 ± 1.02 37.5 ± 1.10 37.5 ± 1.37
24 35.8 ± 3.43 36.1 ± 4.04 37.7 ± 2.15 37.2 ± 4.13 36.0 ± 3.11
TP (g/L) 3 67.7 ± 2.12 67.6 ± 2.57 67.1 ± 2.06 67.4 ± 1.86 68.0 ± 3.04
6 64.6 ± 1.99 64.3 ± 1.59 64.4 ± 1.72 65.0 ± 1.53 64.4 ± 1.78
12 69.0 ± 1.80 68.4 ± 1.79 69.3 ± 1.51 68.8 ± 2.05 68.8 ± 1.80
24 71.3 ± 3.71 71.8 ± 4.79 72.4 ± 3.11 71.7 ± 4.61 71.7 ± 3.74
GLU (mmol/L) 3 5.99 ± 0.83 5.86 ± 0.73 5.86 ± 0.91 6.12 ± 0.79 6.24 ± 0.91
6 5.94 ± 0.81 5.79 ± 0.78 5.87 ± 0.75 6.04 ± 0.78 6.19 ± 0.57
12 5.35 ± 0.59 5.43 ± 0.82 5.26 ± 0.47 5.69 ± 1.16 5.40 ± 0.60
24 4.18 ± 1.10 4.26 ± 1.08 4.36 ± 1.15 4.08 ± 1.12 3.94 ± 1.26
CHOL (mmol/L) 3 2.13 ± 0.21 2.17 ± 0.22 2.14 ± 0.25 2.08 ± 0.22 2.17 ± 0.24
6 2.20 ± 0.27 2.26 ± 0.23 2.23 ± 0.28 2.21 ± 0.27 2.29 ± 0.30
12 2.74 ± 0.35 2.82 ± 0.38 2.85 ± 0.50 2.64 ± 0.45 2.88 ± 0.65
24 4.59 ± 1.60 4.31 ± 2.01 4.03 ± 1.14 4.31 ± 1.98 4.72 ± 1.87
TAG (mmol/L) 3 1.01 ± 0.23 1.14 ± 0.34 1.14 ± 0.33 1.16 ± 0.37 1.03 ± 0.25
6 1.24 ± 0.50 1.29 ± 0.48 1.33 ± 0.47 1.39 ± 0.53a 1.30 ± 0.43
12 1.78 ± 0.59 1.82 ± 0.45 2.01 ± 0.58 2.05 ± 0.67a 2.01 ± 0.56
24 2.08 ± 0.95 2.62 ± 1.26 2.25 ± 0.88 2.40 ± 1.52 2.52 ± 1.47
CREA (mmol/L) 3 37.4 ± 4.34 35.4 ± 4.64 35.9 ± 5.59 36.2 ± 4.29 36.0 ± 4.79
6 42.3 ± 3.67 41.0 ± 3.78 41.8 ± 3.95 42.4 ± 3.52 40.8 ± 3.73
12 43.7 ± 4.80 42.1 ± 3.30 43.1 ± 2.49 42.1 ± 3.35 42.3 ± 3.66
24 30.4 ± 6.90 35.2 ± 22.6 31.0 ± 12.9 30.7 ± 9.20 41.9 ± 33.4
UREA (mmol/L) 3 5.85 ± 0.65 5.61 ± 1.06 5.70 ± 0.85 5.69 ± 0.68 5.78 ± 0.58
6 5.16 ± 0.61 5.02 ± 0.75 5.16 ± 0.59 5.19 ± 0.60 5.10 ± 0.51
12 4.37 ± 0.39 4.32 ± 0.49 4.38 ± 0.46 4.58 ± 0.58 4.28 ± 0.54
24 4.03 ± 0.72 5.00 ± 1.92a 4.32 ± 1.12 4.42 ± 0.91 4.35 ± 1.18
Ca (mmol/L) 3 2.54 ± 0.10 2.55 ± 0.09 2.55 ± 0.09 2.54 ± 0.08 2.54 ± 0.10
6 2.52 ± 0.04 2.52 ± 0.05 2.54 ± 0.06 2.54 ± 0.06 2.52 ± 0.05
12 2.54 ± 0.03 2.55 ± 0.05 2.55 ± 0.05 2.54 ± 0.06 2.54 ± 0.04
24 2.53 ± 0.09 2.54 ± 0.12 2.51 ± 0.08 2.49 ± 0.06 2.54 ± 0.11
Cl (mmol/L) 3 104 ± 2.72 104 ± 1.63 104 ± 1.98 103 ± 1.46 105 ± 2.09
6 102 ± 1.36 102 ± 1.38 101 ± 1.44 101 ± 1.25 102 ± 1.18
12 104 ± 1.31 103 ± 1.54 102 ± 1.33a 103 ± 1.80a 103 ± 1.65a
24 102 ± 1.83 102 ± 1.64 102 ± 1.58 103 ± 2.13 102 ± 2.48
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a Statistically significant difference to the 33% control value based on the 95% confidence interval
Table 15  (continued)
Parameter Time 
(months)
33% Control 11% NK603 33% NK603 11% NK603 + Roundup 33% 
NK603 + Roundup
K (mmol/L) 3 5.34 ± 0.62 5.42 ± 0.55 5.39 ± 0.74 5.35 ± 0.53 5.47 ± 0.86
6 5.06 ± 0.32 5.17 ± 0.59 5.25 ± 0.46 5.32 ± 0.48 5.13 ± 0.37
12 4.80 ± 0.34 4.77 ± 0.23 4.88 ± 0.30 4.81 ± 0.26 4.80 ± 0.27
24 4.61 ± 0.40 4.72 ± 0.49 4.60 ± 0.27 4.85 ± 0.43a 4.69 ± 0.41
Na(mmol/L) 3 146 ± 3.28 145 ± 2.20 146 ± 1.90 146 ± 2.15 146 ± 2.33
6 144 ± 1.80 144 ± 2.23 144 ± 1.78 144 ± 1.69 142 ± 1.18
12 143 ± 2.07 144 ± 1.84 143 ± 1.55 144 ± 2.28 143 ± 2.74
24 143 ± 1.48 143 ± 2.24 144 ± 1.49 144 ± 2.19 143 ± 2.27
P (mmol/L) 3 2.57 ± 0.22 2.43 ± 0.25a 2.56 ± 0.34 2.48 ± 0.19 2.47 ± 0.27
6 2.04 ± 0.26 1.99 ± 0.27 2.05 ± 0.20 2.09 ± 0.21 2.02 ± 0.18
12 1.77 ± 0.17 1.67 ± 0.19a 1.81 ± 0.28 1.71 ± 0.17 1.69 ± 0.16
24 1.67 ± 0.36 1.81 ± 0.41 1.52 ± 0.26 1.64 ± 0.30 1.83 ± 0.62
Table 16  Clinical biochemistry parameters (mean ± SD) in the serum of female Wistar Han RCC rats in the combined chronic toxicity/carcino-
genicity feeding trial with GM maize NK603 at an inclusion rate of 11 and 33% in the diet
Parameter Time 
(months)
33% Control 11% NK603 33% NK603 11% NK603 + Roundup 33% NK603 + Roundup
ALP (µkat/L) 3 0.68 ± 0.14 0.69 ± 0.13 0.71 ± 0.18 0.73 ± 0.14 0.71 ± 0.21
6 0.65 ± 0.13 0.61 ± 0.14 0.63 ± 0.16 0.62 ± 0.13 0.61 ± 0.16
12 0.59 ± 0.13 0.55 ± 0.08 0.60 ± 0.16 0.59 ± 0.13 0.54 ± 0.12
24 0.58 ± 0.18 0.56 ± 0.17 0.60 ± 0.18 0.59 ± 0.12 0.55 ± 0.12
ALT (µkat/L) 3 0.52 ± 0.12 0.53 ± 0.16 0.51 ± 0.10 0.48 ± 0.08 0.57 ± 0.14
6 0.62 ± 0.14 0.61 ± 0.13 0.64 ± 0.12 0.55 ± 0.10a 0.61 ± 0.09
12 0.74 ± 0.18 0.70 ± 0.18 0.71 ± 0.15 0.65 ± 0.27 0.72 ± 0.13
24 0.85 ± 0.23 0.80 ± 0.17 0.81 ± 0.15 0.83 ± 0.15 0.83 ± 0.16
AST (µkat/L) 3 2.14 ± 0.37 2.11 ± 0.40 2.28 ± 0.30 2.09 ± 0.36 2.43 ± 0.48a
6 1.95 ± 0.36 1.84 ± 0.34 2.11 ± 0.56 1.81 ± 0.30 2.09 ± 0.40
12 2.59 ± 0.62 2.52 ± 0.49 2.69 ± 0.50 2.55 ± 0.81 2.73 ± 0.73
24 3.15 ± 0.98 2.92 ± 2.26 3.27 ± 0.68 3.21 ± 0.86 3.10 ± 0.68
ALB (g/L) 3 45.8 ± 2.87 45.8 ± 4.52 45.7 ± 2.96 46.0 ± 3.10 45.2 ± 4.50
6 41.5 ± 1.93 41.8 ± 2.27 42.0 ± 2.93 42.4 ± 2.56 41.3 ± 2.70
12 42.4 ± 1.91 42.5 ± 2.12 43.0 ± 2.14 43.3 ± 3.00 42.4 ± 2.16
24 40.0 ± 2.84 39.5 ± 2.26 39.6 ± 2.49 38.8 ± 2.44 40.1 ± 2.42
TP (g/L) 3 71.3 ± 3.34 70.7 ± 4.41 70.8 ± 3.13 71.5 ± 3.64 70.9 ± 4.01
6 69.6 ± 2.59 69.7 ± 2.73 70.2 ± 3.54 70.2 ± 2.75 69.1 ± 2.37
12 71.9 ± 2.11 71.8 ± 2.30 72.1 ± 2.23 71.9 ± 2.63 71.7 ± 2.72
24 73.8 ± 4.58 74.8 ± 3.98 75.6 ± 3.53 73.0 ± 3.76 74.9 ± 3.46
GLU (mmol/L) 3 5.15 ± 0.53 5.20 ± 0.81 4.93 ± 0.74 5.20 ± 0.77 4.89 ± 0.57
6 5.55 ± 0.67 5.37 ± 0.76 5.26 ± 0.61 5.45 ± 0.74 5.48 ± 0.74
12 5.03 ± 0.87 5.04 ± 0.60 4.75 ± 0.71 5.10 ± 0.70 5.18 ± 0.84
24 4.96 ± 0.86 5.19 ± 1.20 4.75 ± 1.01 4.81 ± 1.16 4.58 ± 0.87
CHOL (mmol/L) 3 1.98 ± 0.34 1.90 ± 0.33 1.83 ± 0.34 1.78 ± 0.22 1.85 ± 0.33
6 2.23 ± 0.42 2.16 ± 0.41 2.06 ± 0.42 2.01 ± 0.32 2.10 ± 0.35
12 2.64 ± 0.50 2.61 ± 0.50 2.57 ± 0.47 2.47 ± 0.45 2.49 ± 0.36
24 3.19 ± 0.76 3.29 ± 1.74 2.97 ± 0.87 2.76 ± 0.80 3.31 ± 1.14
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group at t = 3 months, while it was significantly lower in 
the group fed the 11% NK603 diet than in the control 
group at t = 24 months. K was significantly higher in the 
group fed the 33% NK603 diet than in the control group 
at t = 3 months and in the group fed the 11% NK603 diet 
than in the control group at t = 24 months. Na was signifi-
cantly higher in the group fed the 11% NK603 + Roundup 
diet than in the control group at t = 3 months and in the 
groups fed the 11% NK603 and 33% NK603 diets than 
in the control group at t = 12 months. P was significantly 
higher in the group fed the 33% NK603 diet than in the 
control group at t = 3 months. Apart from these 30 cases of 
significance, the other 450 comparisons involving the 15 
clinical biochemical parameters for males and females over 
4 time points and 4 NK603 groups showed no significant 
differences between the NK603 fed groups and the group 
fed the control diet. Likewise, the equivalence tests at t = 3 
and t = 6 months showed “equivalence” for 225 compari-
sons involving the 15 clinical biochemical parameters, and 
“equivalence more likely than not” for 15 comparisons: one 
or both ELSD confidence limits were outside the interval 
[− 1, + 1] for CHOL in female rats fed the 33% NK603, the 
11% NK603 + Roundup or the 33% NK603 + Roundup diet 
at t = 3 months, or fed any NK603 diet at t = 6 months, and P 
levels in female rats fed the 33% NK603 diet at t = 3 months.
a Statistically significant difference to the 33% control value based on the 95% confidence interval
Table 16  (continued)
Parameter Time 
(months)
33% Control 11% NK603 33% NK603 11% NK603 + Roundup 33% NK603 + Roundup
TAG (mmol/L) 3 0.70 ± 0.13 0.68 ± 0.16 0.63 ± 0.11 0.61 ± 0.13a 0.65 ± 0.08
6 0.82 ± 0.24 0.85 ± 0.40 0.74 ± 0.17 0.74 ± 0.20 0.78 ± 0.19
12 0.96 ± 0.22 0.90 ± 0.23 1.01 ± 0.31 1.21 ± 1.08 0.98 ± 0.25
24 1.32 ± 0.47 1.48 ± 0.65 1.18 ± 0.47 1.39 ± 0.69 1.60 ± 1.58
CREA (mmol/L) 3 44.5 ± 4.04 46.2 ± 5.08 45.2 ± 3.43 47.2 ± 5.23 46.0 ± 4.87
6 43.3 ± 7.27 42.5 ± 4.87 41.5 ± 3.88 43.7 ± 6.78 43.5 ± 3.48
12 43.2 ± 4.47 45.4 ± 3.66 45.2 ± 3.86 46.1 ± 4.99a 44.3 ± 3.46
24 32.4 ± 4.13 35.2 ± 3.65 37.5 ± 6.27a 35.7 ± 5.26a 36.6 ± 5.37a
UREA (mmol/L) 3 5.76 ± 0.54 5.89 ± 0.83 5.83 ± 0.51 5.88 ± 0.50 6.13 ± 0.81
6 5.52 ± 0.55 5.76 ± 0.54 5.64 ± 0.55 5.50 ± 0.42 5.68 ± 0.49
12 4.63 ± 0.44 4.99 ± 0.48a 5.17 ± 0.57a 5.05 ± 0.68a 4.98 ± 0.54a
24 4.67 ± 0.61 4.82 ± 0.83 4.98 ± 0.67 4.93 ± 0.78 4.67 ± 0.75
Ca (mmol/L) 3 2.51 ± 0.06 2.52 ± 0.08 2.53 ± 0.07 2.52 ± 0.08 2.52 ± 0.06
6 2.53 ± 0.05 2.54 ± 0.07 2.56 ± 0.07 2.55 ± 0.07 2.53 ± 0.05
12 2.57 ± 0.04 2.58 ± 0.05 2.58 ± 0.05 2.59 ± 0.06 2.56 ± 0.03
24 2.51 ± 0.06 2.54 ± 0.09 2.51 ± 0.08 2.51 ± 0.06 2.51 ± 0.09
Cl (mmol/L) 3 100 ± 2.44 101 ± 2.70 101 ± 1.99 101 ± 3.49a 101 ± 2.94
6 101 ± 1.58 102 ± 1.45 102 ± 1.67 102 ± 1.48 101 ± 1.85
12 101 ± 1.52 101 ± 1.24 100 ± 1.43 100 ± 1.50 101 ± 1.66
24 97 ± 2.31 96 ± 2.51a 97 ± 2.94 97 ± 2.64 97 ± 2.52
K (mmol/L) 3 4.46 ± 0.41 4.52 ± 0.27 4.54 ± 0.32 4.46 ± 0.39 4.57 ± 0.39
6 4.17 ± 0.32 4.22 ± 0.29 4.56 ± 0.57a 4.32 ± 0.31 4.19 ± 0.35
12 4.36 ± 0.28 4.38 ± 0.40 4.36 ± 0.29 4.37 ± 0.39 4.42 ± 0.52
24 4.34 ± 0.34 3.99 ± 0.39a 4.31 ± 0.49 4.43 ± 0.50 4.32 ± 0.45
Na(mmol/L) 3 142 ± 2.14 143 ± 2.52 143 ± 2.49 143 ± 2.98a 143 ± 2.77
6 142 ± 2.28 142 ± 2.04 142 ± 1.97 142 ± 2.06 143 ± 2.19
12 141 ± 1.92 142 ± 2.28a 142 ± 1.80a 142 ± 2.17 142 ± 2.30
24 142 ± 2.03 142 ± 2.73 143 ± 2.05 142 ± 2.16 141 ± 1.85
P (mmol/L) 3 1.78 ± 0.33 1.87 ± 0.25 2.00 ± 0.33a 1.77 ± 0.43 1.96 ± 0.64
6 1.34 ± 0.21 1.33 ± 0.23 1.41 ± 0.26 1.35 ± 0.26 1.29 ± 0.16
12 1.45 ± 0.23 1.46 ± 0.22 1.56 ± 0.24 1.57 ± 0.37 1.42 ± 0.25
24 1.53 ± 0.22 1.50 ± 0.29 1.71 ± 0.41 1.62 ± 0.22 1.48 ± 0.25
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Table 17  Relative organ weights in male and female Wistar Han RCC rats in the combined chronic toxicity/carcinogenicity feeding trial with 
GM maize NK603 at an inclusion rate of 11 and 33% in the diet (at t = 12 months)
*Statistically significant difference to the control value based on the 95% confidence interval
Organ Relative organ weights (organ weight/body weight × 100)
33% Control 11% NK603 33% NK603 11% NK603 + Roundup 33% NK603 + Roundup
Male rats
 Adrenal glands 0.009 ± 0.001 0.009 ± 0.001 0.009 ± 0.001 0.008 ± 0.001 0.009 ± 0.001
 Brain 0.38 ± 0.03 0.40 ± 0.05 0.39 ± 0.04 0.37 ± 0.04 0.39 ± 0.04
 Epididymides 0.22 ± 0.02 0.24 ± 0.03a 0.22 ± 0.03 0.21 ± 0.03 0.23 ± 0.03
 Heart 0.20 ± 0.01 0.21 ± 0.02 0.22 ± 0.02 0.20 ± 0.01 0.20 ± 0.01
 Kidneys 0.45 ± 0.04 0.47 ± 0.04 0.48 ± 0.08 0.45 ± 0.05 0.45 ± 0.04
 Liver 2.10 ± 0.19 2.08 ± 0.21 2.11 ± 0.14 2.09 ± 0.12 2.01 ± 0.20
 Spleen 0.17 ± 0.02 0.17 ± 0.01 0.18 ± 0.02 0.17 ± 0.03 0.17 ± 0.02
 Testes 0.64 ± 0.05 0.69 ± 0.08 0.65 ± 0.08 0.65 ± 0.06 0.68 ± 0.08
Female rats
 Adrenal glands 0.019 ± 0.003 0.019 ± 0.002 0.019 ± 0.003 0.020 ± 0.003 0.020 ± 0.003
 Brain 0.59 ± 0.06 0.65 ± 0.07a 0.64 ± 0.07a 0.64 ± 0.06a 0.65 ± 0.04a
 Heart 0.25 ± 0.02 0.26 ± 0.02 0.27 ± 0.03 0.26 ± 0.02 0.26 ± 0.02
 Kidneys 0.48 ± 0.05 0.51 ± 0.04 0.50 ± 0.05 0.52 ± 0.05a 0.52 ± 0.04a
 Liver 2.01 ± 0.19 2.05 ± 0.18 2.02 ± 0.15 2.06 ± 0.11 2.06 ± 0.15
 Ovaries 0.018 ± 0.006 0.019 ± 0.003 0.021 ± 0.004 0.021 ± 0.007 0.021 ± 0.006
 Spleen 0.20 ± 0.03 0.21 ± 0.02 0.19 ± 0.03 0.20 ± 0.03 0.22 ± 0.05
 Uterus 0.26 ± 0.06 0.28 ± 0.07 0.24 ± 0.06 0.25 ± 0.05 0.25 ± 0.05
Table 18  Causes of premature death in male rats fed the control diet in the course of the combined chronic toxicity/carcinogenicity feeding trial
Death codes: + 1 = found dead, + 2 = sacrificed moribund; death context: B4 = benign neoplasm, definitely fatal, N4 = malignant neoplasm, defi-
nitely fatal
Animal no. Death week Death codes Primary tumor site/main 
organ affected
Death context Cause of death or intercurrent sacrifice
303 75 + 1 Kidneys Chronic progressive nephropathy
304 87 + 2 Pituitary gland B4 Adenoma; pars anterior
306 99 + 1 Pituitary gland B4 Adenoma; pars anterior
309 84 + 2 Pituitary gland B4 Adenoma; pars anterior
310 87 + 1 Pituitary gland B4 Adenoma; pars anterior
316 86 + 2 Pituitary gland B4 Adenoma; pars anterior
318 98 + 1 – – Urogenital inflammation
319 71 + 2 Pituitary gland B4 Adenoma; pars anterior
321 79 + 2 Abdominal cavity N4 Liposarcoma
323 89 + 1 – – Urogenital inflammation
324 74 + 2 Skin/subcutis N4 Fibrosarcoma
326 96 + 2 Pituitary gland B4 Adenoma; pars anterior
332 71 + 1 Pituitary gland B4 Adenoma; pars anterior
337 87 + 1 Pituitary gland B4 Adenoma; pars anterior
340 75 + 1 Pituitary gland B4 Adenoma; pars anterior
343 92 + 2 Pituitary gland B4 Adenoma; pars anterior
344 75 + 1 Pituitary gland B4 Adenoma; pars anterior
347 20 + 2 Head N4 Squamous carcinoma
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The urinalysis data are summarized in the statistical 
reports by Goedhart and van der Voet (2018a, b, c, d, e). In 
male rats, at t = 3 months, the urine volume was significantly 
lower and the urine leukocyte number as well as the urine 
ketone level were significantly higher in the group fed the 
33% NK603 diet than in the control group. At t = 6 months, 
the urine volume was significantly lower in the group fed the 
33% NK603 diet than in the control group. At t = 12 months, 
the urine volume and the urine volume/body weight were 
significantly lower and the urine osmolarity and the urine 
ketone level were significantly higher in the group fed the 
33% NK603 diet than in the control group, while the urine 
volume, urine volume/body weight and urine leukocyte 
number were significantly lower in the group fed the 11% 
NK603 diet than in the control group. At t = 24 months, the 
urine ketone level was significantly higher in the group fed 
the 33% NK603 + Roundup diet than in the control group. In 
female rats, at t = 3 months, the urine ketone level was higher 
in the group fed the 11% NK603 + Roundup diet than in the 
control group, while the urine volume/bodyweight was lower 
in the group fed the 33% NK603 + Roundup diet than in the 
control group. At t = 24 months, the urine pH was higher 
in the group fed the 33% NK603 diet than in the control 
group. Apart from these 13 cases of significance, the other 
243 comparisons involving 8 urinalysis parameters in male 
and female rats over 4 points in time and 4 NK603 groups 
showed no significant differences between the NK603-fed 
groups and the group fed the control diet.
The relative organ weights in male and female rats at 
t = 12 months are shown in Table 17. In male rats fed the 
Table 19  Causes of premature death in male rats fed the 33% NK603 + Roundup diet in the course of the combined chronic toxicity/carcino-
genicity feeding trial
Death codes: +1 = found dead, + 2 = sacrificed moribund; death context: afinding unilateral in paired organs, B0 = benign neoplasm; B3 = benign 
neoplasm, probably fatal, B4 = benign neoplasm, definitely fatal, N4 = malignant neoplasm, definitely fatal
Animal no. Death week Death codes Primary tumor site/main 
organ affected
Death context Cause of death or intercurrent sacrifice
2 50 + 2 Pituitary gland B0 Adenoma; pars anterior
21 102 + 2 Skin/subcutis Abscess
23 77 + 2 Pituitary gland B4 Adenoma; pars anterior
26 98 + 1 Kidneys Chronic progressive nephropathy
27 97 + 2 Glandular stomach Ulceration
29 100 + 1 Pituitary gland B4 Adenoma; pars anterior
30 103 + 2 Pituitary gland B4 Adenoma; pars anterior
32 77 + 2 Pituitary gland B4 Adenoma; pars anterior
33 51 + 2 Pituitary gland B4 Adenoma; pars anterior
34 96 + 2 Pituitary gland B4 Adenoma; pars anterior
35 54 + 1 – – Pancreatitis
37 77 + 2 Brain N4 Meningioma; malignant
39 78 + 2 Systemic neoplasms N4 Histiocytic sarcoma
40 86 + 2 Pituitary gland B4 Adenoma; pars anterior
43 68 + 2 Pituitary gland B4 Adenoma; pars anterior
44 89 + 2 Adrenal medullas N4a Pheochromocytoma; malignant
46 83 + 2 Kidneys Chronic progressive nephropathy
47 91 + 2 Pituitary gland B4 Adenoma; pars anterior
49 86 + 2 Pituitary gland B4 Adenoma; pars anterior
53 92 + 1 Head N4 Squamous carcinoma
55 89 + 2 Pituitary gland B3 Adenoma; pars anterior
56 99 + 2 Kidneys Chronic progressive nephropathy
57 98 + 2 Pituitary gland B4 Adenoma; pars anterior
58 86 + 2 Pituitary gland B4 Adenoma; pars anterior
60 84 + 1 Adrenal medullas N4a Pheochromocytoma; malignant
66 82 + 2 Pituitary gland B4 Adenoma; pars anterior
68 93 + 1 Pituitary gland B4 Adenoma; pars anterior
70 99 + 2 Pituitary gland B4 Adenoma; pars anterior
49 86 + 2 Pituitary gland B4 Adenoma; pars anterior
53 92 + 1 Head N4 Squamous carcinoma
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11% NK603 diet, the relative epididymides weight was sig-
nificantly higher than that in the control group. In female 
rats, the relative brain weight was significantly higher in the 
four groups fed the NK603 diets, whereas the relative kidney 
weight was significantly higher in the groups fed the 11% 
NK603 + Roundup and the 33% NK603 + Roundup diets 
than in the control group. Apart from these 7 cases of sig-
nificance, the other 57 comparisons involving the 9 relative 
organ weights over 4 time points and 4 NK603 groups for 
males and females were not statistically significant between 
the NK603 fed groups and the group fed the control diet.
The complete histopathology report is available via the 
internet portal CADIMA. As previously mentioned, the mor-
tality rate of the male rats fed the 33% NK603 + Roundup 
diet was significantly higher than that of the correspond-
ing control group. Tables 18 and 19 list the causes of pre-
mature death in male rats fed the control diet and the 33% 
NK603 + Roundup diet, respectively. The most common 
cause of premature death in both groups was a pituitary 
pars anterior adenoma, 12 in the control group and 17 in 
the group fed the 33% NK603 diet. The next most common 
cause of premature death was a kidney chronic progressive 
nephropathy, 1 in the control group and 3 in the group fed 
the 33% NK603 + Roundup diet.
The necropsy findings in the chronic toxicity phase 
recorded in this study were considered to be within the 
normal range of background alterations seen in untreated 
animals of this age and strain (McInnes 2012; Blankenship 
and Skaggs 2013; Cesta et al. 2014). The macroscopic find-
ings in the brain, pituitary gland and mammary glands are 
listed in Table 20. The deformation of the brain correlated 
with the microscopic findings of compression by a pituitary 
neoplasm and mammary nodules and masses correlated with 
the microscopic findings of mammary neoplasia (see below). 
All microscopic findings observed in the rats in the chronic 
toxicity phase are listed in the Supplementary Electronic 
Material’s Table 12. The microscopic findings in the pitui-
tary gland and mammary glands are listed in Table 21. There 
were no statistically significant differences in the number of 
macroscopic and microscopic findings between control rats 
and the NK603-fed rats.
The necropsy findings in the carcinogenicity phase 
recorded in this study were considered to be within the 
normal range of background alterations seen in untreated 
animals of this age and strain (McInnes 2012; Cesta et al. 
2014). The macroscopic findings in the brain, pituitary 
gland, mammary glands and thymus are listed in Table 22. 
The deformation of the brain correlated with microscopic 
Table 23  Neoplastic lesions 
in male and female rats fed the 
33% control, the 33% NK603 
and the 33% NK603 + Roundup 
diets in the chronic toxicity 
phase of the combined chronic 
toxicity/carcinogenicity feeding 
trial with the GM maize NK603
a Number of animals analyzed
b Number of animals with a particular tumor
Organ/lesion 33% Control 33% NK603 33% 
NK603 + Roundup
Males
 Thyroid glands 20a 18 20
  C-cell adenoma – – 1b
 Pituitary gland 20 20 20
  Adenoma; pars anterior 2 3 3
Females
 Lung 20 20 20
  Metastasis – – 1
 Thyroid glands 19 20 20
  C-cell adenoma – – 1
  Follicular cell adenoma – 1 –
 Mammary gland area 20 19 20
  Fibroadenoma 2 – –
 Uterus 20 20 20
  Endometrial stromal polyp – 1 –
 Pituitary gland 20 20 20
  Adenoma; pars anterior 3 3 1
 Abdominal cavity 7 5 6
  Metastasis – – 1
 Bone – – 1
  Osteosarcoma – – 1
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Table 24  Neoplastic lesions in male and female rats fed the 33% control, the 33% NK603 and the 33% NK603 + Roundup diets in the carcino-
genicity phase of the combined chronic toxicity/carcinogenicity feeding trial with the GM maize NK603
Organ/lesion Males Females
33% Control 33% NK603 33% 
NK603 + Roundup
33% Control 33% NK603 33% 
NK603 + Roundup
Systemic neoplasms – – 1a – 1 –
 Histiocytic sarcoma – – 1b – – –
 Malignant lymphoma – – – – 1 –
Heart 50 50 50 50 50 50
 Schwannoma; benign – – 1 – – –
 Metastasis – – – 1 – –
Liver 50 50 50 50 50 50
 Adenoma; hepatocyte 1 2 4 2 1 3
 Cholangiocarcinoma – 1 – – – –
 Metastasis 1 – – – – –
Spleen 50 50 50 50 50 50
 Hemangioma – 1 – – – –
 Hemangiosarcoma – 1 1 – – –
 Metastasis – 1 – – – –
Mesenteric lymph node 50 50 49 50 50 49
 Hemangioma – – 2 2 1 –
 Metastasis – – – – – 1
Kidneys 50 50 50 50 50 49
 Local invasion – – – – – 1
 Tubular cell adenoma – 2 – – – 1
Urinary bladder 50 50 50 50 50 49
 Papilloma – – – – 1 –
Jejunum 50 49 50 50 50 50
 Leiomyoma – – – 1 1 1
Forestomach 50 50 50 50 50 50
 Papilloma; squamous – – 2 – – –
Lung 50 50 50 50 50 50
 Metastasis – – – 3 2 1
Thymus 47 48 44 46 45 47
 Thymoma; benign 4 3 – 6 7 11
 Thymoma; malignant – – 1 – 1 –
Testes 50 50 50 – – –
 Leydig cell adenoma 1 2 1 – – –
Epididymides 50 50 50 – – –
 Mesothelioma – 1 – – – –
Ovaries – – – 50 50 50
 Granulosa adenoma – – – – 1 –
 Granulosa carcinoma – – – – – 1
 Sex cord-stromal tumor; benign – – – 8 3 8
Mandibular lymph nodes 49 50 50 49 49 48
 Metastasis 1 – – – – 1
Pancreas 49 50 49 50 50 50
 Acinar cell adenoma 1 – 1 – – –
 Islet cell adenoma 6 8 2 – – 2
 Islet cell carcinoma 2 1 1 1 1 –
 Metastasis 1 1 – – – –
Thyroid glands 50 50 49 49 50 49
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Table 24  (continued)
Organ/lesion Males Females
33% Control 33% NK603 33% 
NK603 + Roundup
33% Control 33% NK603 33% 
NK603 + Roundup
 C-cell adenoma 5 6 5 6 7 2
 C-cell carcinoma – – – 3 1 –
 Follicular cell adenoma 5 2 1 2 2 –
 Follicular cell carcinoma 2 – – – – –
Adrenal cortices 50 50 50 50 50 50
 Adenoma 4 – 2 3 2 2
 Carcinoma – – – – 1 –
 Local invasion – – – – – 1
Adrenal medullas 50 50 50 48 50 50
 Ganglioneuroma 1 – – – – –
 Neuroblastoma – – – – – 1
 Pheochromocytoma; benign 3 1 1 3 1 3
 Pheochromocytoma; malignant 1 – 3 – – –
Skeletal muscle 50 50 50 50 50 50
 Fibroma – – 1 – – –
 Fibrosarcoma – – – – 1 –
 Rhabdomyosarcoma 1 – – – – –
Skin/subcutis 49 50 50 50 50 50
 Basal cell adenoma – 1 – – – 1
 Fibroma 1 1 2 1 – 1
 Fibrosarcoma 2 – – – – –
 Keratoacanthoma – – 2 – – –
 Lipoma 1 1 1 – – –
 Myxoma – 1 – – – –
 Schwannoma; malignant – 1 – 1 – 1
 Sebaceous adenoma 1 – – – – –
 Squamous carcinoma – – – 1 – –
 Squamous papilloma – – – – – 1
Mammary gland area 49 50 50 50 49 50
 Adenocarcinoma – – – 7 8 5
 Adenoma – – – 2 1 –
 Fibroadenoma – – – 13 16 14
Eyes 49 50 50 50 50 50
 Local invasion – 1 1 – – –
Harderian glands 49 50 50 50 50 50
 Adenoma – – 1 – – –
 Local invasion – 1 1 – 1 1
Brain 50 50 50 49 50 50
 Astrocytoma – – – – – 1
 Granular cell tumor; benign 1 2 – 1 – –
 Granular cell tumor; malignant – 1 – – 1 –
 Local invasion – 1 1 – 1 1
 Meningioma; benign – – 1 – – –
 Meningioma; malignant – 1 – – – –
Prostate gland 50 49 50 – – –
 Adenoma 4 2 – – – –
Seminal vesicles 50 49 50 – – –
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findings of compression by a pituitary neoplasm (see below). 
The findings in the thymus (enlarged and nodule) correlated 
with microscopic findings of thymoma (see below). The 
mammary nodules and masses correlated with microscopic 
findings of mammary neoplasia (see below).
All non-neoplastic microscopic findings observed in 
the rats in the carcinogenicity phase are listed in the Sup-
plementary Electronic Material’s Table 13. There were 
no treatment-related differences in the number of non-
neoplastic microscopic findings between control rats and 
NK603-fed rats. The neoplastic lesions observed in male 
and female rats in the chronic toxicity phase of the combined 
chronic toxicity/carcinogenicity feeding trial with NK603 
are shown in Table 23. All neoplastic microscopic findings 
observed in the rats fed the 33% control, 33% NK603 and 
33% NK603 + Roundup diets in the carcinogenicity phase 
are listed in Table 24. There were no treatment-related dif-
ferences in the number of neoplastic microscopic findings 
between control rats and NK603-fed rats. The observed 
increase in the number of benign thymomas in the female 
group fed NK603 + Roundup at an inclusion rate of 33% 
was not statistically significant when compared to the con-
trol group, or when benign and malignant thymomas were 
analyzed in combination. Moreover, this was also the case 
of pituitary gland and mammary gland tumours.
Table 24  (continued)
Organ/lesion Males Females
33% Control 33% NK603 33% 
NK603 + Roundup
33% Control 33% NK603 33% 
NK603 + Roundup
 Adenocarcinoma – 1 – – – –
 Adenoma 1 – – – – –
Uterus – – – 50 50 49
 Endometrial stromal sarcoma – – – 1 – –
 Endometrial stromal polyp – – – 4 9 3
 Endometrial adenoma – – – 1 – 1
 Fibroma – – – – 1 –
 Local invasion – – – – – 1
 Schwannoma; malignant – – – 1 – 1
Cervix – – – 50 49 49
 Local invasion – – – – – 2
Vagina – – – 48 47 46
 Local invasion – – – – – 2
Pituitary gland 50 50 50 50 50 50
 Adenoma; pars anterior 31 25 29 27 31 34
 Adenoma; pars interior – – – – 1 –
 Carcinoma; pars anterior – 1 – – 1 1
Spinal cord 50 50 50 50 50 50
 Astrocytoma – – – 1 – –
Bone, sternum 49 50 50 50 50 50
 Local invasion – – – – – 1
Preputial glands 1 1 1 – – –
 Adenoma – 1 – – – –
Mediastinal tissue 1 – – 1 – –
 Metastasis – – – 1 – –
Inguinal lymph nodes – – – 2 – –
 Metastasis – – – 1 – –
Abdominal cavity 5 5 7 7 6 3
 Liposarcoma 1 – – – – –
 Metastasis – 1 2 – – 1
a Number of animals analyzed
b Number of animals with a particular tumor
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Discussion
The GM maize NK603 produced for the NK603 + Roundup 
diets to perform the three feeding trials was treated once with 
the glyphosate-containing herbicide Roundup  Transorb® HC 
as described in Materials and Methods following the princi-
ples of good agricultural practice and in conformity with the 
requirements of the KBBE-2013-FEEDTRIALS call “Two-
year carcinogenicity rat feeding study with maize NK603”. 
During the final conference of the G-TwYST project, it was 
argued that the maize should have been exposed to much 
higher concentrations of the herbicide to induce toxic effects 
in the rats during the feeding trials, but this would have contra-
dicted the principles of good agricultural practice. Moreover, 
it should be noted that the toxicity testing of glyphosate as 
such was not within the scope of the above-mentioned call. 
The toxicological evaluation of the active substance glyphosate 
by EFSA relied on a large number of studies (EFSA 2015). 
Glyphosate did not show a genotoxic potential and there was 
no evidence of carcinogenicity in rat or mice studies. Consider-
ing a number of long-term studies in rats, an overall long-term 
No Observed Adverse Effect Level (NOAEL) of 100 mg/kg 
body weight/day was obtained. Based on an overall mater-
nal and developmental NOAEL of 50 mg/kg body weight/
day obtained from several developmental toxicity studies in 
rabbits, an acceptable daily intake (ADI) value of 0.5 mg/kg 
body weight/day as well as an acute reference dose (ARfD) of 
0.5 mg/kg body weight were derived (EFSA 2015).
The glyphosate levels in the near-isogenic non-GM 
maize (Pioneer 8906) kernels as well as in the untreated 
and Roundup-treated GM maize NK603 (Pioneer 8906 R) 
kernels were ≤ 16 µg/kg, which is far below the maximum 
residue level for glyphosate in maize (1 mg/kg) in the Euro-
pean Union (EU-Pesticides Database, accessed on the 5th 
of February 2019). All diets, including the control diet, 
were contaminated with low levels of glyphosate (about 
30–140 µg/kg) not considered to be adverse. The source of 
these low levels of the contaminant is not known; they might 
derive from constituents in the diet other than the maize.
The choice of the rat strain for the G-TwYST feeding tri-
als proved to be extremely important for the type of studies 
to be performed. In the study by Séralini et al. (2012), the 
Sprague–Dawley rat strain was chosen and a very high 
incidence of mammary gland tumors in female animals 
was reported. However, the female Sprague–Dawley rats 
are not suitable to demonstrate treatment-related mam-
mary carcinogenesis because of the very high incidence 
of spontaneously formed mammary gland tumors (Weber 
2017). In the present study, the incidence of mammary 
gland neoplasms in female rats fed the control diet was 
44% (i.e. 7 adenocarcinomas, 2 adenomas and 13 fibroad-
enomas out of 50 rats). Therefore, the Wistar Han RCC rat 
strain used in the present study was a suitable choice to 
test if the GM maize NK603 had the ability to stimulate 
mammary gland carcinogenesis. It should be noted that 
the Wistar Han RCC rat strain has previously been used in 
numerous studies as an experimental model of chemically 
induced mammary gland carcinogenesis (e.g. Abd-Ellatef 
et al. 2017; Ganaie et al. 2017; Smina et al. 2017).
In the 90-day feeding trial with the GM maize NK603 
at an inclusion rate of 11 and 33% in the diets, no adverse 
changes were observed regarding the parameters listed in 
the OECD Test Guideline 408 (OECD 1998) including the 
health status of the animals, the body weights, the haema-
tological and clinical biochemical parameters, the relative 
organ weights as well as the necropsy and histopathology 
findings. Whilst some parameters showed statistically sig-
nificant differences between the various NK603 maize-fed 
groups and the control group, “equivalence” or “equiva-
lence more likely than not” could almost always be estab-
lished for differences between the data of these groups 
and the historical control data. Moreover, the differences 
between test groups and the control group were generally 
small and/or not dose-related further indicating that they 
reflect normal variation and are not biologically relevant. 
Furthermore, there was no correlation between the haema-
tological parameters, the clinical biochemical parameters 
and the relative organ weights showing significant differ-
ences and the necropsy and histopathology findings.
The  T4 level was significantly lower in the sera of male 
rats fed the 33% NK603 diet and in the sera of female rats 
fed the 33% NK603 + Roundup diet if compared to the 
corresponding control groups, but there were no histo-
pathological changes in the thyroid gland, so that these 
changes in the  T4 levels are considered not to be adverse. 
The 17β-estradiol levels in the four groups of female rats 
fed the GM maize NK603 were significantly lower than 
that in the control group. However, these were not accom-
panied by histopathological alterations in any of the ana-
lyzed estrogen-sensitive tissues/organs, so that they are 
considered not to be adverse.
In the 90-day feeding trial with the GM maize NK603 
at an inclusion rate of up to 50% in the diets, no adverse 
changes related to the feeding of the NK603 maize were 
observed regarding the parameters listed in the OECD Test 
Guideline 408 (OECD 1998) including the health status of 
the animals, the haematological and clinical biochemical 
parameters, the relative organ weights as well as the nec-
ropsy and histopathology findings. EFSA (2014) proposed 
an inclusion rate of 50% as a high maize dose in 90-day 
studies in rodents, based on a report by Zhu et al. (2013). 
In the present study, there was no indication of a nutritional 
imbalance if the maize inclusion rate was increased from 33 
to 50% in a subchronic feeding trial, whereby in this case the 
diet composition had to be rebalanced. However, since it has 
been described that the subchronic and chronic feeding of 
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high-protein diets leads to renal damage in rats (Rao 2002; 
Haseman et al. 2003; Wakefield et al. 2011; Aparicio et al. 
2013), the inclusion rate of 33% maize in the diets was cho-
sen by the G-TwYST consortium as the “high dose” of maize 
for the combined chronic toxicity/carcinogenicity study.
Mortality was significantly increased in male rats fed the 
33% NK603 + Roundup diet when compared to the control 
group and was related to the increased number of deaths from 
pituitary neoplasia (12 male rats fed the control diet versus 17 
male rats fed the 33% NK603 + Roundup diet), the most com-
mon cause of death in all groups including controls. However, 
it is important to mention that there was no effect of the 33% 
NK603 + Roundup diet on the overall incidence of pituitary 
neoplasia, i.e. the incidence of pituitary pars anterior adenomas 
in male rats fed the control and the 33% NK603 + Roundup 
diets was 62 and 58%, respectively. The increased mortality 
observed between the 12th and 24th month of the feeding trial 
in male rats fed the 33% NK603 + Roundup diet coincided with 
a strong increase in the body weight of these rats in this period 
of time. These results are in accordance with previous studies 
showing that ad libitum feeding of common high calorie diets to 
rodents in long-term studies results in higher body weights, an 
earlier onset and a higher incidence of spontaneous neoplasms 
such as pituitary gland tumors, as well as a reduced survival 
of these animals and that these effects are not observed in rats 
undergoing a dietary restriction (Keenan et al. 1995a, b; Roe 
et al. 1995; NTP 1997; Nold et al. 2001). Therefore, it is con-
cluded that the increased mortality associated with a higher 
body weight and an increased incidence of pituitary neoplasms 
in male rats fed the 33% NK603 + Roundup diet is not specifi-
cally related to the feeding of this diet (Keenan et al. 1995a, b; 
Nold et al. 2001). In female rats fed the 33% NK603 + Roundup 
diet, the mortality rate was decreased when compared to the 
control female rats, but this difference was not statistically sig-
nificant (p = 0.07). It should be noted that the overall incidence 
of pituitary neoplasms in control and GM maize NK603-fed 
male and female rats did not differ significantly.
The necropsy findings in the chronic toxicity and carcino-
genicity phase of the 2-year feeding trial were considered to 
be within the normal range of background alterations seen 
in untreated animals of this age and strain and their inci-
dence was similar in the control group and the groups fed the 
GM maize NK603. Moreover, the microscopic findings in 
the chronic toxicity and carcinogenicity phase of the 2-year 
feeding trial were consistent with spontaneously occurring 
findings described in the literature, the findings were dis-
tributed randomly among groups, and/or their appearance 
was similar to findings found in controls. The thymoma is 
a typical Wistar rat-related neoplasm, with females more 
affected than males (Murray et  al. 1985; Poteracki and 
Walsh 1998; Weber 2017). The data obtained in the pre-
sent study corroborate these earlier findings, whereby there 
was no statistically significant difference in the incidence of 
benign thymomas in the female control group and the female 
group fed the GM maize NK603 treated with Roundup at 
an inclusion rate of 33% or when benign and malignant thy-
momas were analyzed in combination. Based on the results 
obtained in the three feeding trials performed in the course 
of the G-TwYST project, it is concluded that there were no 
adverse findings related to the feeding with the NK603 or 
NK603 + Roundup diets to rats for up to 2 years.
In the study by Séralini et al. (2012), the most frequently 
occurring anatomical pathologies were observed in the kid-
neys, liver and digestive tract of male Sprague–Dawley rats 
and in the pituitary gland and mammary glands, including 
mammary tumors, in female Sprague–Dawley rats. Moreover, 
Séralini et al. (2012) indicated that the diets containing the 
untreated GM maize NK603 and the Roundup-treated GM 
maize NK603 contained significantly lower levels of the phe-
nolic acids caffeic acid and ferulic acid than the control diet 
and hypothesised that this decrease could explain the higher 
tumor incidence observed in the GM maize NK603-fed rats 
due to less protection afforded by these compounds. In the 
present study, there were no statistically significant differences 
in the number of non-neoplastic and neoplastic findings in the 
above-mentioned organs/tissues between Wistar rats fed the 
control diet and those fed the GM maize NK603-containing 
diets. In line with these findings, the clinical biochemical 
parameters of hepatic (ALP, ALT, AST, TP and ALB) and 
renal function (CREA, UREA and ions) remained, with single 
exceptions, unaltered. Furthermore, the levels of caffeic acid 
were similar in the three batches of control and GM maize 
NK603 containing diets, and this was also the case of feru-
lic acid, whereby much higher levels of this compound were 
measured in batch 1 than in the batches 3 and 5 of all analyzed 
diets due to the different extraction methods applied by the 
two laboratories subcontracted to perform the analyses.
The protocols outlined in the OECD Test Guidelines 
408 for subchronic toxicity testing and 453 for a combined 
chronic toxicity/carcinogenicity testing in rodents (OECD 
1998, 2009) have been designed for the testing of single 
chemicals and provide standard procedures to identify health 
hazards resulting from the repeated exposure to chemicals 
for 90 days, 1 year and 2 years. The OECD Test Guidelines 
recommend the use of at least 10 animals/sex and group for 
subchronic toxicity testing, 20 animals/sex and group for 
chronic toxicity testing and at least 50 animals/sex and group 
for carcinogenicity testing. Chemicals can be administered 
individually to rodents at doses several multiples higher than 
the amount of the chemicals to which humans are exposed 
to test whether they may lead to toxicity. Whole food/feed 
contains a mixture of constituents and can only be adminis-
tered to rodents at rather limited levels to avoid a nutritional 
imbalance. Therefore, it is unlikely that substances present 
in small amounts and with a low toxic potential in whole 
food/feed will cause any observable effects in animal feeding 
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trials (EFSA GMO Panel Working Group on Animal Feed-
ing Trials 2008).
The G-TwYST project has demonstrated that in principle, 
following the approach presented in van der Voet et al. (2017), 
reference groups of animals from previous similar trials in the 
same experimental facility fed with non-GM plant material 
considered to be safe may be used to define a regular band-
width for each endpoint. In practice, it may be difficult to apply 
this approach, e.g. when the variability of analytical methods 
is not stable between the historical and current studies, such 
as for the differential white blood count data in this study, or 
when no historical data are available at all, as for the 2-year 
feeding trial. Traditional statistical tests applied in toxicologi-
cal studies to find differences between test and control groups 
cannot make a distinction between biologically relevant and 
non-relevant effect sizes, and EFSA has recommended to 
put more emphasis on the use of confidence intervals (EFSA 
2011c). Based on a confidence interval approach, equivalence 
tests can be used to show that a test group is within the band-
width defined from historical data obtained in recent studies 
conducted in the same testing facility (“proof of safety”).
Equivalence bandwidths are ideally based on a large pool 
of historical data to capture the whole bandwidth of “safe” 
values. In this study, the available historical control database 
from the same test facility was limited with respect to the 
number of non-GM reference groups. This limitation leads 
to uncertainties, and to wider expected equivalence regions 
than would be obtained with a larger historical database. 
However, the consequences of limited data are taken into 
account in the equivalence tests, effectively by allowing 
larger differences to be equivalent. It may be noted that in 
many cases adverse effect limits are expected to lie far out-
side the equivalence region; thus, our approach is conserva-
tive and does not exclude toxic effects too easily.
An alternative approach is to define bandwidths using 
toxicologically defined quantifications of adverse effects. 
This was performed for nine endpoints, and was reported 
by Goedhart and van der Voet (2017, 2018a, f). However, 
tentative toxicologically defined bandwidths are often only 
available for a few measured endpoints in animal studies, 
and, therefore, an equivalence assessment based on histori-
cal data was preferred.
In the above-mentioned context, the non-GM data 
obtained in the course of the 90-day and 1-year rat feeding 
trials performed in the preceding GRACE project were used 
as historical control data for the equivalence testing in the 
G-TwYST project. G-TwYST proposed and applied a statisti-
cal method for equivalence testing that accounts for statisti-
cal uncertainties in both the current 90-day feeding trials 
and the chronic toxicity testing phase of the 2-year feeding 
trial as well as in the historical reference data (van der Voet 
et al. 2017; Goedhart and van der Voet 2017, 2018a, f). The 
analysis of the data from the rat feeding trials performed in 
the course of the G-TwYST project showed that the cases in 
which equivalence could not be concluded with a 95% sta-
tistical significance and the cases in which significant differ-
ences were observed correspond to no more than about 5% 
of cases across 1424 equivalence tests and 3472 difference 
tests, which is the expected percentage for statistical tests 
using a 5% error level. Moreover, most of the cases in which 
equivalence could not be concluded with a 95% statistical 
significance were related to a larger within-group variation 
of the measurements in the current studies as compared to 
the historical control data, which may be an analytical rather 
than a toxicological reason for a wide confidence interval.
G-TwYST performed a power analysis for quantitative 
findings in 90-day studies estimating effect sizes that could 
be estimated with 80% power (Goedhart and van der Voet 
2018h). For parameters in the list of determinations as advo-
cated by the OECD Test Guideline 408 for testing chemicals 
(OECD 1998) and the EFSA Guidance Document (EFSA 
2011b), such as body/organ weights, haematology and clini-
cal chemistry parameters, a design with 8 cages per group 
in a 90-day study is appropriate for more than 80% of the 
quantitative parameters if deviations of 1.3-fold (+ 30% or 
− 23%) or more have to be detected with at least 80% power.
However, the number of quantitative parameters as 
required to be measured by OECD (1998) is 40–50, and 
the within-group variability in these parameters was found 
in the G-TwYST studies to vary considerably, between 1% 
and 44% expressed as a coefficient of variation. The 10–20% 
of the parameters with a relatively high variability would 
require larger sample sizes to attain the same power as for 
the other parameters. In this study, we found relatively large 
variability for five parameters in both sexes (monocytes, 
eosinophils, BIL, TAG and HGB), and additionally for five 
parameters in female rats only (WBC, LYMA, Neutrophils, 
ALT and uterus weight) (Goedhart and van der Voet 2018h).
G-TwYST performed a whole food/feed combined chronic 
toxicity/carcinogenicity study with 50 animals/sex and group 
for the carcinogenicity phase, which is the minimal number 
requested by the OECD Test Guideline 453 (2009). A power 
analysis for qualitative (yes/no) findings, such as deaths and 
histopathological results, shows that with such a design only 
large differences in single incidences can be detected with at 
least 80% power (Goedhart and van der Voet 2018h). Increas-
ing the number of animals is of limited help, and therefore, 
not a suggested direction for future animal studies. For exam-
ple, in case that the control incidence is 1%, a ninefold rather 
than a 16-fold increase can be detected with 100 instead of 50 
animals/sex and group, and, in the case that the control inci-
dence is 10%, a 2.4-fold rather than a 3.2-fold increase can 
be detected. These levels of changes are often larger than 
what toxicologists would judge as minimal relevant values. 
The low sensitivity is inherent to the qualitative character of 
the findings. These considerations point at the limitations 
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of using whole food/feed studies as an untargeted screening 
approach and underline the necessity to perform such studies 
with clearly targeted hypotheses. It is concluded that, apart 
from setting effect sizes of interest, a prior selection should 
be made of those parameters for which a sufficiently high 
power is needed, before a power analysis can be helpful to 
set the sample sizes for a 90-day animal study in line with 
the OECD Test Guideline 408 (1998) and EFSA documents 
(EFSA 2011b, 2014). The potential usefulness of such stud-
ies lies in the possibility to consider and interpret patterns of 
findings rather than in an analysis of single endpoints.
G-TwYST has confirmed that the variability of quanti-
tative measurements in a combined chronic toxicity/carci-
nogenicity study is in general higher for the measurements 
after 12 and 24 months as compared to 3 or 6 months (Goed-
hart and van der Voet 2018a, g). Therefore, the statistical 
power to detect a certain difference decreases as the duration 
of the study increases, and larger samples may be needed for 
GM plant risk assessment based on 12 or 24 months data. In 
terms of clinical chemistry and haematology measures car-
ried out at the 2-year termination period, scientific opinion 
is split as to their actual value since the concurrent appear-
ance of age-related diseases, such as end-stage kidney and 
hormonal senescence, tends to confound the interpretation 
by increasing the variability in serum parameters associated 
with such effects (Young et al. 2011). For this reason, OECD 
TG 453 leaves the option of whether or not to carry out clini-
cal chemistry and haematology measures after 24 months 
to the discretion of the study director (OECD 2009). Simi-
lar endpoints show less variability at the 12-month than at 
the 24-month termination point in time, but nevertheless do 
show increased variability when compared to those meas-
ured at the 90-day point in time due to the early appearance 
of age-related disease in some animals.
The G-TwYST project provided a broad set of data indi-
cating that the performance of rat feeding trials with whole 
food/feed for the risk assessment of a GM plant did not 
result in the identification of hazards due to the GM maize 
NK603 and is absolutely in line with the earlier risk assess-
ment published by EFSA (EFSA 2003). The obligatory 
risk assessment included, in addition to the detailed safety 
assessment of the newly introduced trait, a comparative 
assessment focusing on potential unintended effects of the 
genetic modification. This comparative assessment included: 
(1) a detailed molecular characterisation of the genetic modi-
fication, i.e. of the inserted sequence as well as of the place 
of insertion; (2) a phenotypic and agronomic comparison 
of the GM variety and its conventional comparator; (3) a 
compositional analysis of the GM variety in relation to its 
conventional counterpart as well as other non-GM varieties 
(reference varieties) (EFSA 2011b).
The 3Rs (Replacement, Reduction and Refinement) 
are guiding principles for a more ethical use of animals in 
laboratory experiments and were first described by Russell 
and Burch (1959). From the 3Rs perspective, it is particu-
larly important to point out that the added value of long-term 
animal studies with whole food/feed should be carefully 
evaluated given the very high number of animals needed (in 
the case of the G-TwYST project: 720, 172 and 268 in the 
combined chronic toxicity/carcinogenicity study, the 90-day 
feeding trial with the 11 and 33% inclusion rates of the GM 
maize NK603 and the 90-day feeding trial with the 50% 
inclusion rate of the GM maize NK603, respectively).
In the original assessment of the GM maize NK603, there 
were no indications that the NK603 maize was not as safe as 
other maize varieties currently on the European market. As 
a result of this lack of hazards, there were no triggers, based 
on general toxicological principles, to perform additional 
animal feeding studies. Therefore, the G-TwYST 90-day and 
long-term animal studies were conducted in the absence of 
a specific hypothesis. The G-TwYST data from 90-day and 
long-term rodent feeding studies confirmed that there are no 
hazards, thereby supporting the results from the initial risk 
assessment performed by EFSA.
In conclusion, in the European GRACE and G-TwYST pro-
jects a series of animal feeding trials were performed (Zeljen-
ková et al. 2014, 2016; this study). This series of studies nei-
ther delivered a scientific basis for the 90-day animal feeding 
trial demanded by the European Commission to be performed 
for each new GM plant variety nor did it indicate that untar-
geted, extended feeding studies with rats fed GM plant mate-
rial are of value for a final confirmation of safety. Thus, an 
added value of animal studies relative to the available non-
animal studies for the risk assessment of GM plants (EFSA 
Scientific Committee et al. 2017) was not substantiated.
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